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Abstract
T1-weighted fast spin echo magnetic resonance imaging (MRI) sequences are able to
depict neuromelanin (NM)-containing structures, such as the Substantia nigra (SN), as
hyper-intense signal areas. NM-MRI can accurately discriminate Parkinson’s Disease (PD)
patients from controls and could potentially be used to evaluate the effects of PD treatment
- either surgery or medication. PD patients that are treated with Deep Brain Stimulation
(DBS) can only undergo 1.5T MRI sequences with specific conditions that prevent the
tissues surrounding the neurostimulators from overheating. However, NM-MRI sequences
are usually not applied at 1.5T due to worse image quality. Nevertheless, it would be
interesting to study how DBS and medication influence the NM signal as a path for a
better understanding of the disease and to potentially evaluate the progression of PD after
the surgical intervention.
Firstly in this work, a NM-MRI sequence was adapted for scanning patients with
implanted DBS systems at 1.5T. To evaluate the performance of the sequence, images
were taken on the same day with 1.5T and 3T MRI systems. The contrast ratio of
both sequences was evaluated and SN areas were measured resorting to a semi-automatic
segmentation algorithm. The assessment of these measurements revealed a good agreement
between the developed sequence and the original 3T sequence.
A second study was carried out, in which SN areas of PD de novo patients were evaluated
before and after two months of initiating pharmacological treatment. The median SN area
tended to be increased after treatment, suggesting a potential increase of NM related to
dopamine therapy.
In conclusion, this work presented the first 1.5T NM-MRI sequence that enables SN
area measurement of patients with implanted neurostimulators, for further investigation
of this method as a diagnostic tool for assessment of disease progression and to better
understand clinical effects on NM-MRI and PD itself.
Keywords: NM-MRI, 1.5T sequence, Deep Brain Stimulation, Parkinson’s Disease, Sub-
stantia Nigra
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Resumo
A técnica de imagem por ressonância magnética (IRM) recorrendo a sequências fast spin
echo permite distinguir estruturas relacionadas com Doença de Parkinson (DP), como a
Substantia nigra (SN), devido ao sinal hiper-intenso proveniente da neuromelanina (NM).
Estas imagens discriminam pacientes com DP de controlos e podem potencialmente avaliar
os efeitos da terapêutica - tanto medicação como cirurgia. Pacientes com DP que são
tratados com estimulação profunda, para evitar o sobreaquecimento dos tecidos em contacto
com os elétrodos durante exames subsequentes à cirurgia, apenas podem ser monitorizados
a 1.5T. Apesar das imagens a 1.5T apresentarem pior qualidade, seria interessante estudar
a influência da estimulação no sinal da NM, na medida em que poderia contribuir para a
monitorização dos doentes após a cirurgia.
Neste trabalho, foi adaptada uma sequência sensível a NM para permitir a monitoriza-
ção a 1.5T de doentes com neuroestimuladores implantados. Para avaliar o seu desempenho,
foram efetuados exames a 3T e 1.5T no mesmo dia. O contraste das mesmas foi avaliado
e utilizou-se uma ferramenta de segmentação semiautomática para medir as áreas da SN.
As áreas medidas com a sequência desenvolvida e a sequência original a 3T mostraram
uma boa concordância.
Adicionalmente, as áreas da SN de pacientes DP de novo foram medidas antes e após
dois meses de iniciar a medicação. Verificou-se uma tendência de aumento da SN após
tratamento, sugerindo um potencial aumento da neuromelanina relacionado com a terapia
de dopamina.
Para concluir, este trabalho apresentou a primeira sequência de IRM sensível a neuro-
melanina que permite medir as áreas da SN de pacientes de DP com neuroestimuladores
implantados. Esta sequência pode vir a ser utilizada como uma ferramenta de avaliação da
progressão da doença e contribuir para um melhor entendimento dos efeitos da terapêutica
neste tipo de imagens assim como aprofundar os conhecimentos da DP.
Palavras-chave: IRM, Neuromelanina, Neuroestimuladores, Doença de Parkinson, Subs-
tantia Nigra
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Introduction
1.1 Motivation
Parkinson’s Disease (PD) is a neurodegenerative disorder that affects over 10 million people
in the world. This disease is characterized by a progressive loss in motor functions, which
translates in incapacitating symptoms such as resting tremor, rigidity, postural instability
and others. Even though a cure for PD has not yet been found, it is possible to reduce its
symptoms by taking anti-Parkinson medication and/or going through surgery.
A recurrent technique used to improve some of Parkinson’s disease symptoms is the
electrical stimulation of the Subthalamic Nucleus (STN). However, after implantation of
the neurostimulators, said patients become restricted to 1.5T Magnetic Resonance (MR)
images of the patient due to the potential over heating in the implanted electrodes on 3T
MR scanners, which can cause serious damages to the tissue in contact.
Neuromelanin (NM)-sensitive Magnetic Resonance Imaging (MRI) is a promising tech-
nique to allow in vivo visualization of the pathological changes in NM-containing structures
that occur in degenerative diseases such as PD. PD is accompanied by progressive neu-
ronal loss of the Substantia Nigra (SN) neurons. These neurons contain a dark pigment
- neuromelanin - whose paramagnetic properties lead to a T1 hyper-intense signal of the
SN on NM-MRI. Therefore, this type of imaging has been increasingly used to evaluate
PD since it can depict the NM-related contrast.
The majority of studies have applied NM-MRI at 3T due to its improved resolution and
signal-to-noise ratio (SNR). However, as it was already mentioned, due to safety reasons
PD patients with implanted neurostimulators can only be imaged with 1.5T MRI systems.
1
CHAPTER 1. INTRODUCTION
1.2 Aim of this work
The overall aim of this work was to assess potential effects of PD therapeutic using NM-
MRI.
Having in mind the reduced availability of 3T MRI systems, this work’s first goal was
to adapt the 3T clinical standard sequence into a 1.5T NM-MRI sequence, which could
accurately depict the neuromelanin-corresponding SN area. In an initial stage, the general
1.5T NM-MRI sequence’s feasibility was assessed through comparison with the currently
used 3T sequence.
A further aim of this work, in order to assess potential efects of DBS on NM-MRI,
was to adapt the sequence to safely scan PD patients with implanted neurostimulators.
The 1.5T NM-MRI sequence adapted for patients with implanted DBS systems was then
compared with the previously developed general 1.5T sequence.
An additional goal was to establish the repeatability of the SN areas obtained with the
applied semi-automatic segmentation algorithm, for all tested MRI sequences.
Furthermore, another aim of this work was to enable to uncover the direct effects of
medication on the measured NM-SN area of PD patients and, in turn, to obtain a deeper
knowledge on the role of dopamine in NM production, potentially building towards a full
understanding of PD.
1.3 Thesis Outline
This thesis consists of six different chapters and is followed by an appendix.
In the current chapter, in addition to this outline, it is included the motivation for
this work, presenting the problems regarding 3T MRI in PD patients with implanted DBS
systems, explaining what is the role of NM-MRI sequences and what is the aim of this
study.
The second chapter, Theoretical Principles and State of the Art, is a literature review
of the most important concepts used in this dissertation, starting with the basic notions
of MRI required for understanding the development of a sequence. Also in this chapter
is provided an overview of PD, DBS and how they relate. Apart from this, a review on
NM-MRI as a diagnostic and research tool for PD is made. Finally, the statistical tests
later used in this work are briefly described.
The third chapter marks the beginning of the presentation of the experimental work,
discussing the necessary changes applied to the acquisition parameters used to develop
the 1.5T NM-MRI sequence. Following this, a characterization of the image processing is
made as well as a presentation of the methods used to validate the segmented SN areas
against the current gold standard method (manual segmentation).
In the fourth chapter, another study for sequence validation is presented. This time,
the validated 1.5T NM-MRI sequence is adapted to be safely used in the examination of
patients with implanted DBS systems.
2
1.3. THESIS OUTLINE
The fifth chapter is dedicated to the influence of another type of PD therapeutic -
medication - in the NM present in the SN. It starts with a review on the dopamine
metabolism, which is helpful for a better understanding of the results. The NM-MR
images of PD patients before and after the initiation of medication are presented and
analyzed.
Lastly, in the sixth and final chapter of this dissertation, the conclusions regarding the
results obtained are summed up and some suggestions for future studies are presented.
3
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Theoretical Principles and State of the Art
2.1 Magnetic Resonance Imaging
2.1.1 Physical Fundamentals
Magnetic Resonance Imaging is a technique that relies on the Hydrogen nuclei´s magnetic
properties. The 1H nucleus is frequently used in imaging acquisition since it is the most
abundant proton in the human body and possesses nuclear spin. Due to this nucleus
property, and according to the quantum principles, when the proton is submitted to a
magnetic field the spin becomes restricted to one of two discrete directions: parallel (low-
energy state) and anti-parallel (high-energy state) to the external magnetic field. Since
most of the MR principles can be explained using a classical approach, from now on the
model used to describe the MR phenomena will be the classical one.
A nucleus with spin has an axis of rotation that can be represented as a vector with a
certain magnitude and orientation. The magnetic moment is parallel to this axis [1]. In
the absence of a magnetic field the spins are randomly oriented, which results in a null net
magnetization (Figure 2.1).
Figure 2.1: Representation of the protons in the absence of an external magnetic field.
Their spin vectors are randomly oriented (left side). The sum of these vectors is null (right
side). Adapted from [1]
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CHAPTER 2. THEORETICAL PRINCIPLES AND STATE OF THE ART
When an external magnetic field is applied to the protons, B0, the nuclear spins align
with B0 and start to precess around the axis of rotation at a certain rate of resonance.
This resonance frequency, also called Larmor frequency, is proportional to the external
magnetic field: ω0 = γB0, wherein γ is the gyromagnetic constant, specific to each nucleus.
Proton magnetization can be divided into two components - longitudinal and transverse
- taking into account their movement. The parallel coordinate (z) to B0, or longitudinal,
is constant with time and positive. The transverse coordinates (x and y), or perpendicular
to B0, are non-null and vary with the precession. In the direction perpendicular to B0, the
spins orientations are randomly distributed whereby the resulting transverse magnetization
is null.
When a Radiofrequency (RF) pulse is applied with the Larmor frequency, resonance
occurs and there is energy absorption by the nucleus. This energy transfer consists of
a shift from the lower state of energy to the higher one. The Flip Angle (FA) defines
the angle of rotation of the magnetization from the longitudinal axis to the transverse
plane and is proportional to the RF pulse duration and B1 field amplitude. When the RF
pulse stops and the system returns to its natural state, relaxation, which is accompanied
by an emission of electromagnetic energy, occurs. The signal which originates from this
phenomenon is called Free Induction Decay (FID) and it is characterized by the time
constant T ∗2 . This constant is affected by spin-spin interactions and heterogeneities in B0
which lead to an acceleration on the dephasing of spins, following the expression:
1
T ∗2
= 1
T2
+ 1
T2i
(2.1)
Where the time constant T2 is tissue specific and describes the relaxation curve of
the transverse magnetization, related to spin-spin interaction. T2i is related to the inho-
mogeneities of the magnetic field. The longitudinal relaxation is the result of the energy
transfer from the spins to the net. Its decay curve is characterized by the time constant
T1, which is also tissue specific. This last constant is always greater than T2 for a given
tissue.
2.1.2 MR Pulse Sequences
RF pulse sequences enable the acquisition of MR signals, which contain information about
the scanned object. These signals are later digitalized to fill in a matrix, called K–space.
In MRI spatial encoding is achieved through the application of gradient fields - frequency
and phase encoding. Each line of the K–space corresponds to the data obtained from
a single phase encoding gradient and the columns correspond to the frequency encoding
gradients. Finally, the inverse Fourier Transform is applied to the K–space to form an
image.
MR pulse sequences have many variations, however there are two main base sequences:
Spin Echo (SE) and Gradient Echo (GE).
6
2.1. MAGNETIC RESONANCE IMAGING
SE sequences consist in the application of a 90◦ RF pulse followed by a 180◦ RF pulse
(Figure 2.2), or in the case of a Multi-Echo SE sequence, multiple 180◦ pulses. The initial
90◦ pulse causes the previously explained resonance. The 180◦ pulses, echo creators, lead
to phase coherence between spins which reverses field heterogeneity effects, enabling a
T2-weighted image acquisition. In conventional SE, the phase encoding gradient is turned
on only one time per Time of Repetition (TR) interval, which corresponds to a single line
of the K–space being filled per TR interval. Typically MRI sequences are characterized
by two parameters: Time of Echo (TE) and TR. TE is the time between the 90◦ pulse
application and the center of the first echo. TR is the time between two excitation pulses,
90◦.
Figure 2.2: Representation of a Spin Echo Sequence. Adapted from [2].
In Fast Spin Echo (FSE) sequences, multiple 180° pulses and echoes follow each 90°
pulse. However, unlike Multi-Echo SE, in FSE sequences after each echo, the phase
encoding gradient is rewound and a different phase encoding is applied to the following
echo (Figure 2.3a). This enables a faster filling of the k-space with reduced number of
repetitions (number of TRs) and hence a decreased acquisition time (Figure 2.3b). The
number of echoes in each repetition (during the TR interval) is called the Turbo factor.
a FSE technique b Corresponding K-space
Figure 2.3: Representation of a Fast Spin Echo Sequence. For each 180° pulse a different
phase encoding is applied (a). The resulting MR signals define the filling of the K-space
(b), in which each colored line corresponds to the signal collected during the sequence
period displayed in the same color. The signals with more information correspond to the
center of the K-space. Adapted from [3].
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GE sequences are in the category of rapid imaging, like FSE, but differ from SE
sequences essentially because no 180◦ pulses are applied. Since GE sequences only apply
RF excitation pulses, bipolar gradients are used to generate echoes. This bipolar gradient
is composed of a dephasing gradient followed by a rephasing gradient (Figure 2.4). Usually
these sequences are combined with a FA lower than 90◦ due to the decrease in transverse
magnetization that results from it. Thereafter the longitudinal recovery is faster which
allows a reduction in TE and TR, decreasing the acquisition time.
Figure 2.4: Representation of a Gradient Echo Sequence. The application of a RF pulse
originates a FID signal, characterized by the time constant T ∗2 (left side). By applying a
dephasing gradient, an accelaration in dephasing of the spins occurs. This process is then
reversed with the application of a rephasing gradient, thus forming a gradient echo (right
side). Adapted from [4]
2.1.3 Generating image contrast
Each human body tissue can be characterized by different signal intensities in MRI. These
differences between tissues - tissue contrast - can be obtained through means of varying the
acquisition parameters, TE and TR. The three most conventional types of image contrast
are: T1-weighted, T2-weighted and Proton Density (PDn)-weighted.
To acquire a T1-Weighted Image (WI) it is necessary to use a short/medium TR so that
differentiation between longitudinal magnetization of tissues happens and the signals reflect
substantially the T1 values of each tissue. Additionally, TE is related to the transverse
relaxation which implies, for this weighted image, using a short TE that suppresses T2
effects (Figure 2.5). In the case of a 90º pulse application, the interaction of the chosen
TR and TE with the resulting longitudinal and transverse magnetization can be observed,
respectively, in equations 2.2 and 2.3.
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Mz =Mo (1− e−
TR
T1 ) (2.2)
Mxy =Mo e−
TE
T2 (2.3)
In order to minimize the influence of T1 on the image, a long TR must be applied. Thus,
the longitudinal magnetization of tissue returns to its equilibrium state before the next
excitation pulse is applied. This allows the acquisition of a T2-WI or PDn-WI (Figure 2.5).
Therefore, by varying these parameters it is possible to obtain different tissue contrasts
and emphasize given structures.
Figure 2.5: Influence of parameters TE and TR on the resulting weighted images. Adapted
from [5].
2.1.4 Spatial Resolution and SNR
Good spatial resolution on a MR image is an essential requirement to acquire quantitative
anatomic information. Spatial resolution depends on the voxel sizes that in turn are
determined by the matrix dimensions, Field of View (FOV) and slice thickness.
The matrix size depends on the number of phase encodings in one direction and
the number of frequency encodings on the other direction – perpendicular to each other.
Usually, more frequency encodings are applied because it enhances spatial resolution
without increasing the acquisition time. The FOV is the area size that the matrix will
occupy. Thus, the bigger the FOV, for a given matrix, the worse is the spatial resolution.
The slice thickness corresponds to the voxel depth. This is, usually, the biggest dimension
9
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in 2D sequences. Hence, of the three dimensions, slice thickness is the one that presents
the worst resolution.
Signal-to-Noise Ratio (SNR) is another measure of image quality and is calculated as
the ratio of the mean signal intensity over the standard deviation of the noise. Equation
2.4 shows how SNR is extremely influenced by the selected acquisition parameters of a 2D
MRI sequence:
SNR=K ∗ (voxelvolume) ∗
√
NPE ∗NSA
bandwidth
(2.4)
Where constant K represents the influence of several hardware dependent factors, field
strength, pulse sequence type parameters, such as TE and TR, and tissue dependent
parameters. NPE is the number of phase encoding steps and NSA (number of signals
averaged) represents the number of times that each phase encoding is repeated.
SNR is directly proportional to the field strength. As the field strength increases, there
is an increase in the longitudinal magnetization due to the larger number of protons aligned
with the B0 axis. This translates in a signal enhancement for each voxel and, consequently,
higher SNR.
By increasing the TR, higher values for the longitudinal magnetization can be reached
and, with this, higher SNR. However, it is important to have in mind that high repetition
times can be accompanied by a reduction of T1 effects, altering the contrast. With a lower
TE, there is more signal and hence better SNR. Another important parameter that can
alter the SNR is the number of averages (NSA) acquired for an image. As the number of
averages increases, so does the SNR.
A greater spatial resolution implies a smaller voxel size and with a reduction in voxel
size there is less signal from each voxel, resulting in a worse SNR - as it can be observed
in equation 2.4. Therefore, when acquiring a MRI there is always a compromise between
spatial resolution and SNR.
2.2 Parkinson´s Disease
2.2.1 Pathophysiology of PD
PD affects over 1% of the world population over 55 years old and almost 3% of the
population over age 70 [6]. In Europe, PD’s crude prevalence rate ranges from 65.6 per
100000 to 12500 per 100000 [7]. PD’s etiology is still unknown, even though several studies
hypothesized that degeneration is caused by a combination of factors such as ageing,
genetic predisposition and environmental factors, such as toxins, infections, mitochondrial
dysfunction and oxidative stress [8, 9, 10].
PD is a progressive, neurodegenerative disease that affects the nerve cells of the pars
compacta portion of the substantia nigra (SN) situated in the mesencephalon (Figure 2.6).
The SN is divided into two anatomical areas that present distinct functions - Substantia
10
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Nigra pars compacta (SNc) and Substantia Nigra pars reticulata. However, only the SNc is
directly associated with PD [10]. The SNc neurons produce neurotransmitters - dopamine
– which are responsible for controlling motor functions. The dopamine is then released
by the SNc to the striatum - brain structure that has control over the motor information
exchange between the spinal cord and the brain [11]. Another important characteristic
of PD is the degeneration of the locus coeruleus (LC), located in the tegmentum of the
upper pons. Such results in a reduction of the neurotransmitter norepinephrine on the
frontal cortex, hypothalamus and other brain structures [12].
Figure 2.6: Midbrain section of the mesencephalon illustrating relevant structures for
this work, such as the substantia nigra, the interpeduncular fossa and the decussation of
superior cerebellar peduncle. Adapted from [13]
In PD, the SNc neurons suffer a progressive loss resulting in a decrease in the production
of dopamine. This leads to a reduction in stimulation of the dopamine receptors localized on
the striatum, which in turn can cause secondary effects of mostly enhanced activity of other
movement-related brain structures (Figure 2.7). The internal segment of the globus pallidus
becomes overactive which can lead to appearance of tremor. The subthalamic nucleus is
also hyper-stimulated leading to an inhibitory effect on the thalamus and consequently
reduced output to the motor cortex, which explain the symptoms [11, 14]. Only when
around 60% to 80% of the nerve cells are depleted, PD symptoms start to manifest [15]. The
main symptoms are resting tremor, muscle rigidity, bradykinesia (slowness of spontaneous
movement), hypokinesia (diminished range of motion) and postural instability [16].
11
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Figure 2.7: Brain anatomy. Brain structures associated with PD: Striatum, Substantia
Nigra, Thalamus, Subthalamic Nucleus and Globus Pallidus. Adapted from [11]
The Unified Parkinson’s Disease Rating Scale (UPDRS) is the most accurate and
commonly used rating tool to assess severity and status of PD [17]. The Movement
Disorder Society developed this scale, incorporating four main components; Part I evaluates
“nonmotor experiences of daily living”; Part II evaluates “motor experiences of daily living”;
Part III registers “motor examination” and Part IV concerns “motor complications.” For
each component, there are several questions that are classified using a scale ranging from
0 (normal) to 4 (severe).
PD is an incurable neurodegenerative disease that has few treatments for the attenua-
tion of symptoms and trying to slow its progression. The most used anti-Parkinson drug
is L-dopa, also known as levodopa, which is a natural dopamine precursor [18]. When PD
treatment using medication is no longer effective in the reduction of motor complications,
recurring to surgery with Deep Brain Stimulation (DBS) is a common procedure.
2.2.2 Neuromelanin
Many studies have revealed that the SNc is constituted by neurons with high concentrations
of neuromelanin [19]. This concentration linearly increases with age [20], however in PD
patients there is a decrease of NM which is believed to be connected with the dopamine
loss (Figure 2.8).
Neuromelanin is a dark insoluble pigment found highly concentrated on dopaminergic
neurons of the SNc, confined in cytoplasmic organelles. Additionally, NM has high affinity
for metals, particularly iron, and it has been demonstrated that the main neurons who
store iron also contain neuromelanin [20]. A few studies have demonstrated that the iron
concentration is increased in PD patients [22], possibly as a response to the dysfunctional
nigral neurons and consequent iron release. Nevertheless, this topic remains controversial,
12
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Figure 2.8: Midbrain sections showing the neuronal loss in a PD brain (left) and a healthy
subject brain (right). The neuronal loss in the SN of the PD brain can be seen due to the
neuromelanin’s properties. Adapted from [21]
since other published studies did not find significant differences in iron concentration
between PD and controls [23].
Due to its composition, NM seems to have two very distinct roles: protective and toxic.
It has a protective function because of its antioxidant properties that defend the cells
from redox active metals. However, when the neuromelanin-containing neurons die, NM
is released to the surroundings where, due to its insolubility, it stays and can potentially
release metals and toxic compounds that may damage other tissues and worsen PD [20].
2.3 Deep Brain Stimulation
2.3.1 Introduction to the technique
DBS is a commonly used treatment for patients with PD [24, 25]. This technique delivers
electrical stimulation to deep brain target structures, such as the STN, via electrodes
and an Implantable Pulse Generator (IPG) implanted into a subcutaneous pouch in the
subclavicular area (Figure 2.9).
It is believed that DBS stimulates axons of the STN, triggering a sequence of events
that leads to a dopamine release of the SN neurons. When STN stimulation occurs, either
excitatory glutamatergic inputs are sent directly to the SN dopamine cells or excitatory
cholinergic/glutamatergic inputs are sent indirectly through the Pedunculopontine Tegmen-
tal Nucleus (PPT) to the SN [27] (Figure 2.10). With this, there is an enhancement of
dopamine release from the SN neurons to the striatum, motor control is slowly regained
and thus an improve in PD symptoms can be achieved [27].
A series of studies have been developed with the aim of exploring DBS effects on PD
patients [24, 25], mostly inspired in investigating the safety of these patients with DBS
systems implanted.
The DBS system is constituted by electrodes (Figure 2.11), an Implantable Pulse
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Figure 2.9: Medtronic Deep Brain Stimulation System components. Adapted from [26].
Figure 2.10: Illustration of the STN electrical stimulation showing the effects on PPT and
SN, which lead to dopamine release on the striatum. Adapted from [27].
Generator (IPG) and extension cables that connect these components. Each electrode
has four metal contacts with neural tissue. When voltage is induced, either through a
single contact and the IPG - monopolar stimulation - or between two contiguous contacts
- bipolar stimulation -, current is produced and flows to the target tissues [28].
2.3.2 Safety Concerns
The main safety concern with DBS systems in MRI is the sudden increase of temperature
on the electrode contacts. This temperature rise results from the effect of the RF pulses
applied during the acquisition of the MRI on the DBS system, also known as the antenna
effect [29]. The antenna effect suggests that the extended cables used in DBS act as antenna
wires, which are sensitive to the electric component, as opposed to the magnetic component
of the RF radiation used in MRI. When the electromagnetic waves reach the antenna,
they have associated electric charges and consequently currents. When resonance occurs,
these currents flow to the tip of the antenna, where the electric energy stays concentrated,
14
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Figure 2.11: The Medtronic 3389 DBS electrodes for bilateral stimulation. Each electrode
has four metal contacts spaced between each other. Contacts 0 and 8 are the deepest. The
arrows represent the extension cables that connect the electrodes to the IPG. Adapted
from [28].
resulting in a localized increase of temperature [30].
Two case studies reported MR Imaging-related accidents in patients with DBS systems
implanted [31, 32]. Thus, establishing the safety of performing MRI in patients with
subthalamic deep brain stimulators became a priority. Nowadays, safety considerations
have to be taken into account when performing MRI scans in patients with neurostimulation
systems, namely the impossibility of using 3T MRI systems on these cases [33]. The
strong magnetic field characteristic of 3T machines implies an increase of the RF pulses
frequency and consequently induces more easily a temperature rise on the tissues, which was
demonstrated to be harmful [30]. An evaluation of safety using 1.5T MRI was performed
and it was proved that the temperature increase can be controled at said field strength
[34]. Since then, numerous 1.5T MRI sequences have been tested confirming that it is safe
to obtain these images on patients with implanted neurostimulators [35], as long as a few
additional restrictions are obliged.
The most important considerations, in addition to the usage of a 1.5T MRI scan, are: to
turn off the DBS stimulation while performing the scan and when defining the parameters
for the MRI sequence, the Specific Absorption Rate (SAR) presents a threshold imperative
to respect [33]. These limits are described in Table 2.1. The SAR measures the rate at
which energy is absorbed by the body. The purpose of this metric is to indirectly evaluate
the temperature increase on body tissue, caused by the RF energy deposition [35]. SAR is
proportional to the power of 2 of the resonance frequency, as shown in equation 2.5 [36]:
SAR∝B20 ∗ (flip angle)2 ∗ (RF duty cycle) ∗ (patient size) (2.5)
Thus, as the frequency of the pulsed RF field increases with the field strength of the
magnet, SAR also increases [37]. In order to obtain SAR reduction without changing the
field strength, a decrease on the number or amplitude of the RF pulses can be made.
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The SAR estimate is, however, dependent on the patient’s size and mass and it varies
according to the model used by each MRI manufacturer [38]. Therefore, the B1+RMS
parameter was recently presented as a more accurate measure of potential implant heating
in MRI scanners [39] (Table 2.1). B1+RMS is the time-averaged RF magnetic field compo-
nent responsible for the creation of an MR image. B1 is the magnetic field generated with
the application of RF pulses, which presents rotating components, the positive one being
responsible for the protons flip that generates the MR images. B1+RMS is thus a measure
of the magnitude of the positive rotating component of the B1 magnetic field necessary to
create an MRI in 10 seconds [38].
SAR (W/Kg)
B1+RMS (µT)Whole body Head
3T ≤2 ≤3.2 ≤2.8
1.5T with DBS system ≤0.1 ≤0.1 ≤2
Table 2.1: SAR and B1+RMS maximum values that ensure safe examinations - at 3T and
at 1.5T with implanted DBS systems.
2.4 NM-MRI sequence
In 2006, Sasaki et al [40] developed the first MRI sequence capable of identifying in vivo
neuromelanin-containing structures, namely SN and locus coeruleus, from the surrounding
brain. The proposed NM-MRI sequence was a T1-weighted FSE applied at 3T.
The images corresponding to this sequence revealed band-like high signal areas in the
posteromedial portion of the cerebral peduncle visualized at the level of the midbrain
(Figure 2.12b) [40]. This finding agrees well with the presence of NM in the SN, in in
vivo slices (Figure 2.12a), suggesting that the NM-containing SN neurons are related to
the high-signal intensity. This relation was later confirmed by another study, which noted
a clear correlation between the signal intensity and the density of the NM containing
neurons, for different parts of the SN [41]. Furthermore, the signal intensity in PD patients
was revealed to be reduced in comparison with healthy subjects, in agreement with the
progressive loss of SN neurons that occurs on PD patients.
A possible explanation for the obtained contrast is that NM’s paramagnetic properties
facilitate its orientation with the direction of the external magnetic field, resulting in an
acceleration of the T1 relaxation and thus explaining the high signal intensity of the NM
[40]. Additionally, it was suggested that the high iron concentration in the SN may have
contributed to the T1-shortening effects [40]. Although a posterior study found no apparent
influence of iron deposition on the signal intensity of the SN [41], the influence of iron in
MRI is still not completely understood [43].
Another essential requirement for the correct identification of the SN signal is the
choosing of the slice orientation. The sections must be set it the oblique axial plane,
oriented perpendicular to the fourth ventricle floor, starting from the inferior border of
16
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Figure 2.12: Neuromelanin-sensitive and conventional magnetic resonance images of the
substantia nigra. Axial sections at the level of the midbrain; macroscopic specimen (a)
and MR images obtained at 3T with NM-MRI (b), T1-WI (c), T2-WI (d) and PDn-WI
(e). The arrows on (a,b) indicate the SNc. On (d) the large arrow points to the SN and
the small arrow to peduncular fibers. The arrowheads on (e) point to the SN. Adapted
from [42].
the pons to the posterior commissure region [43] (Figure 2.13). The slice orientation in
NM-MRI is particularly important due to the small number of slices, three at best, in
which the SN is visible. Additionally, in NM-MRI sequences the slice thickness is usually
larger than the resolution, which can cause partial volume effects and hence potentially
hinder the SN detection. For these reasons, slight alterations in the slice angulation could
alter significantly the delineation of the SN in the MR images, emphasizing the importance
of choosing a correct slice orientation.
Figure 2.13: Correct slice orientation of a neuromelanin-sensitive MRI sequence. Adapted
from [43].
Conventional T1-weighted SE sequences have failed to capture NM-generated signals
(Figure 2.12c). Also, on T2-WI, the SN region shows low signal intensity and contrast
(Figure 2.12d). On a proton density-WI, the substantia nigra can be identified as a gray-
matter signal area, however the SNc cannot be distinguished from the substantia nigra
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pars reticularis (Figure 2.12e) [44].
Meanwhile the majority of studies have been applying T1-weighted FSE sequences at
3T (Table 2.2) with good spatial resolution [45]. The SNR at 3T is twice as higher than at
1.5T and at 3T the relaxation time T1 of the brain tissue is higher. This implies a signal
suppression of the surrounding brain tissue caused by the longer T1 [46] and, consequently,
an enhancement of the neuromelanin-contrast [40]. Additionally, FSE sequences are associ-
ated with increased incidental Magnetization Transfer (MT) effects [47]. All these factors
contribute to the successful visualization of NM-containing tissues but the key factor is
believed to be the MT effects that result from the multiple applications of RF pulses.
MT is a process where spins transfer energy (magnetization) from bound protons to
free protons. Usually the MR signal reflects only the magnetization associated to free
protons due to their long T1 and T2 values. The bound protons, which have very short
T2 values, reach magnetization saturation very quickly. In the case of FSE sequences, the
application of multiple 180º pulses facilitates the magnetization saturation of the bound
protons leadind to a magnetization transfer to the free protons. With this, a reduction in
the MR signal associated to the bound protons occurs, resulting in an enhanced contrast
[48].
Recently, a 3D Gradient Echo sequence with an additional MT pre-pulse was proposed
for visualizing NM at 1.5T [49] but no subsequent studies have been reported at this field
strength. This sequence revealed to have the needed resolution for enabling the observation
of SN and locus coeruleus. The acquisition parameters of the referred sequence, as well as
of previously mentioned related NM-MRI sequences are presented in Table 2.2 for a more
easy comparison.
With the GE sequence, the determinant factor for a good achievement of NM contrast
was the application of a Slice Selective Off Resonance Sinc (SORS) pulse with Saturation
Transfer Contrast (STC), which generates MT contrast. When the surrounding brain
tissue signal is suppressed by the STC, the contrast between this tissue and the NM is
enhanced, also due to the T1 reduction caused by the NM and confirming the theory that
MT effects are reduced in tissues that contain paramagnetic substances [50]. This study
demonstrated that it is possible to visualize NM contrast at 1.5T due to the applied MT
pulse. Another study [51] corroborated this theory and showed that GE sequences with
MT preparation pulses are able to produce better contrast than FSE sequences, which
rely solely on incidental MT effects [52]. Such is consistent with the observation that
most NM-MRI contrast is derived from MT effects. In [53], a NM-MRI protocol with a
single slice of the SN was tested and it was not possible to distinguish the SN from the
surrounding brain tissues, thus corroborating the importance of MT effects in NM-MRI.
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2.5 Statistical Tests
2.5.1 Non-parametric Tests
When performing statistical tests, two contradictory hypotheses are stipulated. These
statistical hypotheses are conjectures about the distribution of one or more random vari-
ables. The first hypothesis, designated as null hypothesis (H0), assumes that there is no
difference between the parameters. The second hypothesis or alternative hypothesis is
denoted as H1 and represents the opposite of H0 [56].
The goal of a statistical test of an hypothesis is not to determine whether the statement
is true or not, but to determine if it is consistent with the observed sample. As so, the
null hypothesis should only be rejected when the observed data has a very low probability
of being true. By defining a p-value lower than 0.05 as significant, if the obtained result is
indeed significant (p < 0.05) the null hypothesis is rejected. Otherwise, if (p ≥ 0.05), H0
is supported [56].
There are two main statistical tests: parametric and non-parametric tests. Non-
parametric tests are applied when no assumptions that the data is influenced from a
given probability distribution are made, as opposed to parametric tests. Non-parametric
tests are usually used in cases with small samples (n < 30), also these are more accurate
than parametric tests when the normality of the data cannot be assumed [57].
For these reasons, in the present study, the following non-parametric methods were
applied: Friedman test and Wilcoxon signed rank test.
The Friedman test is used to test for differences between three or more related groups,
where the hypotheses to be tested are [58]:
• H0: All groups came from the same population or from populations with the same
distribution;
• H1: Not all groups have the same distribution.
The Wilcoxon signed rank test is used to compare paired samples. The samples must
be dependent within the par (paired samples) and independent between pairs [59]. The
tested hypotheses of the Wilcoxon test are:
• H0: The median difference between paired samples is zero;
• H1: The true location shift is not equal to zero.
2.5.2 Intraclass Correlation Coefficient
For any measurement procedure to be used in clinic practice, reliability of the method
has to be established. The chosen method for analyzing test-retest reliability of the
semi-automatic algorithm is the Intraclass Correlation Coefficient (ICC). This is the only
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measure of reliability that measures both correlation and agreement between measurements
[60].
The ICC can assume different forms according with the type of study that is being
performed. Its values always range from 0 to 1, with values closer to 1 representing stronger
reliability. As in the present study test-retest reliability is being assessed, ICC estimates
and their 95% confidence intervals were calculated based on a single measurement, absolute
agreement, 2-way mixed-effects model, as defined by McGraw and Wong [61].
2.5.3 Bland-Altman Method
In this study, the agreement between two methods of measurement - SN areas taken with
the 1.5T sequence and with the 3T sequence - had to be assessed. To do so, the graphic
statistical procedure proposed in 1983 by Altman and Bland [62] was performed. This
method evaluates the agreement between two quantitative measurements by calculating
the mean difference and limits of agreement of the said measurements.
The resulting graphic is a scatter plot XY, considering that the obtained measurements
from the two different methods are represented by the variables A and B, in which the Y
axis represents the difference between the paired measurements and the X axis the average
of those measures (Figure 2.14). The Bland-Altman plot has a confidence interval of 95
%, meaning that 95 % of the data should lie within ±1.96SD (standard deviation) of the
mean difference. The bias is represented by the gap between the mean difference of two
measurements and the X axis, which corresponds to zero differences [63].
Figure 2.14: Example of a Bland-Altman plot of differences between method A and B Vs.
the mean of the two measurements. The bias and the confidence interval limits are also
represented. Adapted from [63].
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While other agreement analyses, such as the ICC, have defined criteria to evaluate
the level of agreement between measurements, the Bland-Altman method only provides
the intervals of agreement and it us up to the user to interpret whether those limits are
acceptable or not.
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Validation of a 1.5T NM-MRI sequence
Neuromelanin-sensitive MRI is a promising technique to allow the visalization in vivo of the
pathological changes in NM-containing structures that occur in degenerative disorders and
has recently also been applied to psychiatric disorders [42]. The majority of studies have
applied NM-MRI at 3T due to its improved resolution and SNR. However, availability and
safety reasons due to patients with implantable devices such as neurostimulators, cardiac
pacemakers and cardioverter-defibrillators may prevent imaging at this field strength [64,
65]. This chapter describes the development of a 1.5T NM-MRI sequence through adapta-
tion of the commonly used 3T NM-MRI sequence in clinic practice. These two sequences
were compared using a semi-automatic segmentation algorithm applied to the SN, aiming
to establish the feasibility of the developed 1.5T sequence. Additionally, differences in the
contrast ratio of the tested sequences were assessed.
3.1 Materials and Methods
3.1.1 Sample Description
Twelve individuals (4 males and 8 females), with ages ranging from 38 to 85 years (mean
age: 62.5 ± 13.1 years) were included in the present study. From this pool, seven subjects
were diagnosed with PD by a movement disorders specialist according to the PD UK
Brain Bank criteria [66]. The remaining five subjects had still an undetermined diagnosis
but presented movement-related disorders. Patients were recruited from the Movement
Disorders Unit of Hospital of Santa Maria-Lisbon.
All subjects provided informed consent for the examinations performed on this study.
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3.1.2 Imaging Protocol
To develop a 1.5T NM-MRI applicable in clinic practice and with an adequate reproducibil-
ity and image contrast, the 3T T1-weighted FSE sequence currently used at Hospital of
Santa Maria-Lisbon was the starting point from which the 1.5T sequence was adapted
from. The necessary changes are discussed next in subsection 3.1.2.1.
The 3T sequence had the following acquisition parameters: repetition time/echo time
of 606/10ms; turbo factor of 3; FOV of 220×190 mm2; matrix size of 548×474 (pixel size
of 0.40×0.40 mm2); slice thickness of 2.5mm with no gap; four averages; Parallel Imaging
(PI) with reduction factor of 1.5 and an acquisition time of 8:35 min.
The acquisition parameters of the 1.5T sequence were: TR/TE of 600/10ms; turbo
factor of 3; FOV of 220×180 mm2; matrix size of 440×361 (pixel size of 0.50×0.50 mm2);
slice thickness of 2.5mm with no gap; four averages; no PI acceleration, and an acquisition
time of 9:45 min.
Both systems used T1–weighted FSE sequences and all images were acquired with an
8-channel SENSE head coil. All data were acquired with a 3T MRI (Achieva 3.0, Philips
Medical Systems, Best, Netherlands) and a 1.5T MRI systems (Intera 1.5, Philips Medical
Systems, Best, Netherlands). Each subject underwent a single scan in each MRI system
with both acquisitions being performed on the same day, by a random order according to
the availability.
In both cases, the sections were carefully set in the oblique axial plane perpendicular
to the floor of the fourth ventricle, starting from the posterior commissure to the inferior
border of the pons.
3.1.2.1 Analysis of the acquisition parameters
The changes applied to the original sequence were made with the purpose of ensuring
sufficient resolution on the 1.5T sequence to enable the visualization of the SN. Adding
to this, an effort to change as few parameters as possible was made so that at the time of
the analysis, variability sources will have been reduced.
In order to compensate the reduced SNR typical of 1.5T images, the size of the ac-
quisition matrix was reduced, leading to a slightly coarser pixel size (0.5x0.5 mm2) and
consequently a smaller spatial resolution was obtained. The FOV was slightly decreased,
although it was not significant so that it would change spatial resolution. These slight
changes in the FOV values are very common in the clinic considering that this parameter
has to be adjusted according to the head size of each individual patient.
Despite the potential change on T1 contrast due to the alteration of field strengths,
TR and TE were kept along the same values, as we expected the intrinsic MT effects to be
dominant. The time of repetition was slightly reduced. Nevertheless, this reduction did
not have much of an impact on the acquisition time due to the deactivation of SENSitivity
Encoding (SENSE).
24
3.1. MATERIALS AND METHODS
SENSE is a parallel imaging technique that enables the reduction of the number
of phase encoding steps and reconstructs the missing data taking into account the coil
sensitivity variation between channels [67], thus enabling a shorter acquisition scan (8:35
min). However, the reduced image information necessary to obtain a shorter scan time
results in a diminished SNR related to the reduction factor:
SNRPI =
SNR√
R
(3.1)
, where R represents the reduction factor by which the number of k-space samples
is reduced. Therefore, considering that 1.5T sequences predictably present a worse SNR
when compared to 3T sequences, parallel imaging was not applied to the developed 1.5T
sequence and its acquisition time increased (9:45).
3.1.3 Imaging Analysis
Image processing was performed using the OsiriX program (Version Lite) [68]. This
program combines visualization features of medical images with various processing tools
and is more easily applicable in clinic practice than similar implemented processing in
Matlab.
To assess if the developed 1.5T NM-sequence is effective and comparable to the al-
ready existing 3T NM-sensitive MRI sequence, as well as able to detect changes in the
neuromelanin-containing structures, it is essential to define a method that allows quanti-
tative measurement of the SN.
There have been several reports [51, 55, 69] of SN quantification with different segmen-
tation methods. Most of these studies used two-dimensional (2D) sequences. However,
there were divergences regarding the type of SN measurements – area [54, 69] or volume
[51, 70]. Since 2D segmentation of a single slice is simpler and faster and therefore more
easily included in clinic practice, the SN quantification in this study was made through
measurements of the SN area from a single slice. Additionally, the thick slices used in the
study (2.5mm) that are necessary to ensure sufficient SNR, can lead to partial volume
effects thus originating subjective SN volume measurements.
Once the type of SN measurement is defined, there are two possible segmentation
methods – manual or automated. In the present study, a semi-automated segmentation
method optimized in a previous Master Thesis [71] was applied. Furthermore, in order to
evaluate the repeatability and feasibility of the algorithm, manual segmentation of the SN
was used as gold standard. All the segmentation process is described next in subsection
3.1.3.1.
3.1.3.1 Segmentation method
The NM hyper intense signal is typically visible in three slices (Figure 3.1). The middle
slice - 3.1b, which presents the largest SN area, was chosen for measurements. In two cases
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there were doubts in slice selection owing to the fact that the NM-SN area was visible on
more than three slices. For these two subjects only, slices that were visually similar at
1.5T and 3T were chosen.
a Lower midbrain b Center midbrain c Upper midbrain
Figure 3.1: Axial sections at different levels of the midbrain showing the substantia nigra as
a hyper intense signal area. The middle slice (b) was the one chosen for SN measurements.
In order to compensate for the reduced SNR present in NM-MRI that can have an
effect on segmentation, a Guassian blur filter, which is incorporated in the OsiriX features,
was applied to the selected slice (Figure 3.2b).
a Original image b Filtered image
Figure 3.2: Selected axial middle slice for SN measurements before (a) and after (b) the
application of the Gaussian blur filter, showing a clear blur effect of the applied filter.
The Guassian blur filter uses a Gaussian function to calculate the kernel (Figure 3.3)
that will be applied to each image pixel. During the image convolution, the pixel that
is being analyzed is given the highest weight – corresponding to the center pixel of the
mask, whilst the neighboring pixels which are covered by the mask, are given increasingly
lower weights as the distance between them and the main pixel increases. This filter is
commonly used in image pre-processing because it reduces the noise in the image, thus
facilitating the segmentation that follows. Additionally, compared to the other filter types
already implemented within Osirix, the Gaussian blur filter was demonstrated in [71] to
have the best performance in the SN segmentation. The used filter has a kernel dimension
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of 5× 5 pixels and a Full Width at Half Maximum (FWHM) of 2 pixels.
Figure 3.3: Representation of the colored image corresponding to the 5x5 Gaussian blur
kernel. The color-bar on the right shows how the data values correspond to the image,
with the highest weight being given to the center pixel.
With the selected filtered image displayed, there are some adjustments that need to be
done before the application of the segmentation algorithm. The OsiriX software enables to
modify the displayed contrast, thereby facilitating the user in visualizing the SN area, as
well as zooming in and rotating the image - all helpful tools for the correct identification
of the substantia nigra.
The OsiriX 2D semi-automatic segmentation tool has three available algorithms: Thresh-
old, Neighborhood and Confidence. This last algorithm was chosen as it was shown in [71]
to be the most practical and efficient method for segmentation of the NM-corresponding
area. The Confidence algorithm requires the definition of three parameters, which define
the inclusion criteria: multiplier, number of iterations and initial radius, whose correspond-
ing values for the correct identification of the SN were, as defined in [71] - 2,2 and 1,
respectively (Figure 3.4).
The Confidence algorithm is based on a commonly used segmentation technique –
Region growing. This technique enables growth of regions that were previously marked
with seed regions. That is, starting with the initial selected set of pixels, the neighboring
pixels are posteriorly evaluated based on the inclusion criteria to decide whether they
should be included in the segmented region or not.
Owing to the fact that the algorithm is based on Region growing, the relevance of
developing sequences that successfully depict the neuromelanin-containing structures and
optimizing image contrast is particularly relevant. A possible source of concern is the
placing of the seed region, which influences the identification of the Region-of-Interest
(ROI). Thus, to minimize the seed placing error and consequent variability of the ROI, a
straight line crossing the interpeduncular fossa was drawn (Figure 3.5a), just like it was
done in [71]. Along the referred line the SN voxel with the most hyper intense signal was
chosen.
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Figure 3.4: OsiriX segmentation tool interface that enables the definition of the segmenta-
tion algorithm and respective parameters. In this study, the chosen segmentation algorithm
was Confidence and its parameters were 2 - Multiplier, 2 - Number of Iterations and 1 -
Initial Radius.
After the application of the semi-automatic algorithm, it was common for the segmented
SN regions to present gaps (Figure 3.5b). Yet, anatomic examinations have shown that the
SN is a structure which does not present gaps. For this reason, a last filter - Brush closing -
was applied and with this, the gaps that were not being accounted for the area calculation
became filled (Figure 3.5c). Finally, with the semi-automatic SN region correctly delineated,
the corresponding ROI was saved as well as some of its characteristics, such as area and
mean signal intensity, which are available in the OsiriX software.
SN segmentation using the semi-automatic tool explained above was performed three
times for each side of the brain in order to assess test-retest reliability. The three repeated
measures of the SN ROIs were performed on different days to avoid biasing.
The left and right ROIs of each image were considered independent regions, as it is
common in PD for one side to present a more accentuated loss of dopaminergic neurons
of the SN, making a total of 24 SN regions to be studied. For each SN region, manual
segmentation was also performed on a different day. The SN manual contours were made
resorting to an OsiriX tool that enables the user to freely draw over the image, in order
to obtain the sought segmented region, and adjust the said region if needed (Figure 3.6).
The manual ROIs were all validated by a certified neuroradiologist (Dr. Sofia Reimão)
and saved to be used as gold standard.
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a Pre-segmentation b Confidence algorithm
c After Brush closing
Figure 3.5: SN semi-automatic segmentation process. First a line is drawn crossing the
interpeduncular fossa (a). Then, a pixel along the line is chosen and the Confidence
algorithm generates the region-of-interest accordingly (b). At last, the Brush closing filter
is applied to ensure that the selected SN area is completely filled (c).
a Manual segmentation b Semi-automated segmentation
Figure 3.6: Example of the application of a manual (a) and semi-automated (b) segmen-
tation of the SN region on a neuromelanin-sensitive MR image, using the OsiriX software.
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3.1.3.2 Similarity Analysis
The analysis of the SN areas is very effective to evaluate quantitative differences in the
dimensions of the ROIs, thus enabling the assessment of neuropathological changes. Never-
theless, there is no information regarding spatial distribution of the SN segmented regions.
A very common method used in medical images to assess the reproducibility of seg-
mented regions is the Dice Similarity Coefficient (DSC) calculation [70, 72]. This coefficient
quantitatively measures the spatial overlap between two segmented regions, complementing
the analysis of the comparison between SN regions.
In this study, the overlap between the semi-automatic SN ROI and the reference manual
segmentation was determined using the DSC:
DSC = 2 area(SNsa ∩SNm)
area(SNsa)+ area(SNm)
(3.2)
where area(SNsa) and area(SNm) represent SN areas for a semi-automatic ROI and
corresponding manually-segmented region, respectively, and ∩ represents the intersection
operator. The DSC ranges from 0, where the segmented regions do not intersect at all to
1, which indicates exact overlap.
An application in Matlab (R2016, The Math Works, Natick, MA, USA) was created
to estimate the DSC. The developed interface (Appendix A.1) enables the loading and
visualization of two DICOM images, the visualization of the two segmented regions overlap
with two possibilities – just showing the region that resulted from the overlap (Figure 3.7c)
or displaying the two initial regions and its overlap in different intensities (Figure 3.7d) -
and calculates the DSC. Additionally, the application allows the user to zoom in and out
on all images and to save the resulting image.
The two DICOM images that were compared with the Matlab application contained
a semi-automatic SN region and the other its corresponding manual segmentation. For
the application to work, these images had to be taken from the OsiriX program displaying
solely the isolated segmented regions. Considering this, the developed script treats the
image as binary and assigns the value 1 (white) to every pixel that does not have intensity
0 (black), displaying the region-of-interest as white and the surroundings as black (Figures
3.7a and 3.7b).
3.1.3.3 Image contrast Analysis
FSE NM-MRI sequences rely solely on incidental MT effects to distinguish the NM-
containing structures. Furthermore, image contrast at 1.5T is expected to be diminished
when compared to 3T. Considering this, it is imperative to evaluate the obtained NM-
related contrast in order to assess the feasibility of the 1.5T FSE sequence that is being
tested.
Because SN segmentation is performed after application of the Gaussian blur filter
- the first step of the segmentation pipeline – described previously in 3.1.3.1, it would
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a Binarized semi-automated region b Binarized manual segmented region
c Binarized overlap region d Two segmented regions and its overlap
Figure 3.7: Segmented regions after binarization (a,b) and two available display options for
visualizing the resulting overlap (c,d) - with the Matlab application for DSC calculation.
be interesting to assess Contrast Ratio (CR) differences between field strengths after
the filter application. However, knowing that image filtering may potentially affect the
contrast, it is also necessary to evaluate the significance of these differences. Thereby, CR
was measured both before and after the filter application, keeping the used ROIs in the
exact same positions. Additionally, in order to assess whether differences in CR affect the
segmentation, CR was calculated on the same slices that were used to measure the SN
areas – for both field strengths.
To evaluate the CR, the fraction ISN/IDP was calculated where ISN represents the
mean signal intensity of two 6.0mm2 square ROIs (one for each side of the brain) located in
the SN portion matching an imaginary line crossing the interpeduncular fossa. IDP is the
mean signal intensity of the decussation of the superior cerebellar peduncles determined
using a circular reference ROI (diameter of 4.0 mm) (Figure 3.8). The mean signal
intensities were measured with OsiriX.
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Figure 3.8: Example of a NM-MR image, after the application of a Gaussian blur filter,
with two square ROIs in the SN and a circular reference ROI located in the decussation
of the superior cerebellar peduncles. The mean signal intensities of the ROIs, needed for
the contrast ratio calculation, are displayed by the OsiriX software.
3.1.4 Statistical Analysis
All statistical analyses were performed with the R software, version 3.3.3. (R Foundation
for Statistical Computing, Vienna, Austria), and a p-value lower than 0.05 was considered
significant.
For each subject, semi-automatic repeated measurements (area and DSC) were obtained
at three different times for each magnetic field strength. The Friedman test (2.5.1 was
applied for within-subject comparisons of these measurements. As will be shown later
(Section 3.2), since no differences were observed between repetitions, the Wilcoxon signed
rank test (2.5.1) was then performed to evaluate pair-wise comparisons between the first
semi-automatic area estimate and the corresponding manual area. Both analyses consist
of non-parametric tests.
To assess the reliability of the semi-automatic SN measures (area and DSC), a two-way
random ICC evaluating absolute agreement (2.5.2) was tested. This coefficient and its
95% Confidence Intervals (CI) were calculated for all subjects and for each magnetic field
scanner. The ICC values were interpreted according to the criteria set by Landis and Koch
[73] that considers an ICC of (0.8 - 1) as an almost perfect agreement between groups and
(0.6 - 0.8) as substantial agreement.
The agreement between SN areas obtained at the two different magnetic fields – 1.5T
and 3.0T - was assessed by using the Wilcoxon signed rank test and the Bland-Altman
method (2.5.3).
Lastly, the Wilcoxon test was also used to investigate CR differences measured before
and after the filter application, to assess whether pre-processing influences significantly
the CR values. The comparison of the SN contrast ratio obtained at 1.5T and 3T was also
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performed using the Wilcoxon test, both prior to the filtering and following it.
3.2 Results
No significant differences were observed with the Friedman test for either field strengths
when comparing between the three repeated estimates of the SN area (Table 3.1). Nev-
ertheless, a higher p-value was obtained at 3T (p=0.9893) than at 1.5T (p=0.5308), as
it was expected. The Friedman test applied to the DSC of the different samples of the
semi-automatic SN ROIs also revealed no significant differences between the samples for
1.5T (p=0.9892) or 3T (p=0.2430) – Table 3.1.
Although the Friedman tests proved that there were no significant differences in size and
spatial distribution between the repeated semi-automatic measures for both field strengths,
the repeatability of the algorithm still needed to be assessed. To that end, the intraclass
correlation coefficients were calculated for area and DSC at 1.5T and 3T.
The ICC and CI for the SN areas estimated with the semi-automatic algorithm using
1.5T and 3T images are also shown in Table 3.1. A high ICC was obtained in both
cases. The SN areas measured at 3T, have an almost perfect agreement between the
repeated measures (ICCArea, 3T: 0.913, p<0.001) with a very narrow CI for all ROIs.
The agreement of the SN areas estimated from 1.5T images was considered substantial to
almost perfect with a wider CI, but a large ICC value (ICCArea, 1.5T: 0.815, p<0.001).
The ICC for the DSC measurements (Table 3.1) indicated substantial agreement, with
a wide CI, for both magnetic fields. At 3T the ICC revealed a substantial agreement
(ICCDSC , 3T: 0.777, p<0.001). The DSC agreement within the semi-automatic ROI
estimated from 1.5T images was almost perfect (ICCDSC , 1.5T: 0.817, p<0.001).
The segmented SN areas estimated with the semi-automatic algorithm (Figure 3.9)
showed excellent test-retest reproducibility and revealed good overlap with the correspond-
ing manual segmentations (Figure 3.10). The mean DSC considering the three repetitions
was 0.72 [0.67-0.78] (median; [Q1-Q3]) for 1.5T and 0.77 [0.72-0.81] for 3T. According to
the criteria defined in [74], the DSC obtained at 3T was excellent (>0.75) and at 1.5T
can be considered as good overlap (0.6-0.75). Once again the measurements at 3T showed
better results than at 1.5T, as expected.
Considering the excellent reproducibility of the semi-automatic segmentation algorithm,
only the first SN areas taken with the algorithm were considered in the remaining analyses.
No significant differences were detected when comparing the first semi-automatic and
corresponding manually determined SN areas using the Wilcoxon pair-wised comparison,
either at 1.5 T (p-value=0.1747) or 3.0T (p-value=0.0574). These results corroborate
that the semi-automatic segmentation results are reproducible in images acquired with
both magnetic fields and that the SN measures are valid to be used as these were not
significantly different from the gold standard (manual measurements).
The analysis with Bland-Altman plot for the SN areas showed good agreement between
the semi-automatic measurements obtained at different magnetic fields (Figure 3.11) with a
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a Plot of SN areas at 1.5T
b Plot of SN areas at 3T
Figure 3.9: Box and whisker plot of SN areas (mm2) estimated with the semi-automatic
algorithm (three repeats represented by S1, S2 and S3) for 1.5T (a) and 3T (b).
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a Plot of DSC at 1.5T
b Plot of DSC at 3T
Figure 3.10: Box and whisker plot of DSC representing overlap between the segmented
SN areas, estimated with the semi-automatic algorithm (three repeats represented by S1,
S2 and S3) and the manual ROI for 1.5T (a) and 3T (b).
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small positive bias of 1.56 mm2. However, its limits of agreement ranged from -13.07 mm2
to 16.2 mm2, which can be considered as a relatively wide range. Since the Bland-Altman
results were not conclusive on their own, the Wilcoxon test comparing the same areas was
performed and confirmed that the SN ROI estimated from the images collected at different
magnetic fields were not significantly different (p-value=0.3596).
Figure 3.11: Agreement analysis of SN areas between the two different sequences – 1.5T
and 3T. The plot shows a bias between the mean differences of 1.56mm2 and an agreement
interval ranging from -13.07 mm2 to 16.2 mm2, with a 95% confidence interval.
When comparing the corresponding CRs calculated before and after the filter appli-
cation, the Wilcoxon test revealed a really marked significant difference between CRs
(p-value<0.0001). To evaluate differences between the images obtained at different mag-
netic fields, the statistical Wilcoxon test was applied to compare the CR measures. This
test showed no significant differences between CR values, both before the filter application
(p-value=0.0640) and after (p-value=0.0523), although both values are very small. The
distribution of CR values in the SN evaluated at 1.5T and 3T, for both studied cases were
also observed (Figure 3.12) and are very similar. The median CR, before image filtering
was applied, at 1.5T (1.177) was lower than at 3T (1.205), as expected, and the range at
1.5T [1.141 – 1.223] narrower than at 3T [1.118 – 1.316]. The median CR, after the filter
application, at 1.5T (1.163) was lower than at 3T (1.193) and the range at 1.5T [1.135 –
1.200] narrower than at 3T [1.123 – 1.303].
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Figure 3.12: Dispersion of contrast ratios (CR) of Substantia nigra at 1.5T and 3T, before
(left side) and after (right side) the Gaussian blur filter application. In both cases, no
significant difference was found between field strengths, although the median CR was lower
for 1.5T than 3T.
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3.3 Discussion
Segmentation of the SN using NM-MRI has been previously applied mainly at 3T to differ-
entiate between PD and controls [40] and to investigate disease progression by comparing
between PD groups [69]. Since differences between SN areas may be subtle, it is important
to guarantee a good reliability of the segmentation method. This is particularly relevant
for application of the methodology at 1.5T, as the CR is lower than at 3T and because the
segmentation method had been previously optimized for the SN visualization at 3T [71].
To evaluate the quality of the segmentation at both field strengths, ROI manual
delineation was used as the gold standard, despite being time consuming and operator
dependent, as it is the only method that ensures a good anatomical correlation. Area
and spatial distribution comparison between semi-automatic and corresponding manual
segmentation revealed an excellent agreement between methods and hence, an excellent
reliability of the semi-automatic algorithm for both field strengths.
An excellent repeatability was obtained for the SN measurements (area and DSC) with
high ICC values at both field strengths (Table 3.1), indicating a good level of reliability
of the semi-automatic segmentation procedure. Even so, the SN measurements at 1.5T
presented a wider confidence interval and a slightly reduced agreement compared to 3T.
The most likely explanation is that since region growing segmentation relies on image
contrast to delineate the included region, and as 1.5T images have lower CR (Figure 3.12),
segmented regions tended to be more variable. Consequently, the algorithm’s precision was
diminished at 1.5T as expected. Nevertheless, the semi-automatic segmentation algorithm
is reproducible at 1.5T.
While studying differences in contrast ratio between field strengths, two possible CR
measurements were tested: before and after the application of the Gaussian blur filter -
first step of the SN segmentation pipeline. The CR measured after the filter application
is statistically smaller when compared to the original CR measures, which is expected
considering that the said filter blurs the image, thus diminishing the contrast. Nevertheless,
despite image filtering altered the measured CR, the percentage difference is much smaller
than between images acquired with different field strengths. In addition, when comparing
CR differences between field strengths, regardless of image filtering, differences are observed.
Therefore, SN CR differences between field strengths can be evaluated after the filter
application. In fact, such differences may be responsible for the wider variability of the
semi-automatic SN areas at 1.5T.
Another factor that may lead to errors in ROI analyses is related to the anatomical
training of the observer, as the measurement method partly depends on the placement of
the seed region made by the observer. In the future, it would therefore be beneficial to
evaluate the interrater reliability associated to these SN ROI measurements.
In this study, the small positive bias observed with the Bland-Altman method between
scanners is an indicative that, on average, the segmented areas measured at different
magnetic fields were similar, with the 1.5T segmented SN areas appearing to be slightly
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larger than at 3T. This increase of the 1.5T segmented SN areas over the 3T measurements
can be due to the lower CR present in 1.5T NM-sensitive images, which leads to a reduced
precision in the delineation of the SN ROI. Nevertheless, the observed limits of agreement
between ROIs taken from images collected with different magnetic fields were wide. A few
factors (differences in SNR, CR, head positioning, and potentially motion artifacts) could
all have contributed to these variabilities.
A further source of variability, in the study between field strengths, is the difference in
spatial resolution of the two sequences as a slightly coarser resolution was used at 1.5T to
minimize SNR differences, as explained in section 3.1.2.1. It is common for these types of
studies, which investigate differences between similar MRI sequences, to try to maintain
as many parameters with the same value, in order to reduce sources of variability [51].
However, in this case, spatial resolution at 1.5T was altered for the referred reason and
resolution at 3T (the standard clinical sequence) had to be maintained to not compromise
the comparison as a mean for validation. Parallel imaging acceleration was not employed
at 1.5T for the same reason, despite resulting in a longer acquisition time. Since the
scanner only provided the final averaged images, and as PI was used at 3T, SNR could not
be reliably evaluated at 3T [75] and it was therefore not compared between field strengths.
Even though the two scans for each subject were made on the same day, head positioning
is likely to have varied between exams. On this note, the DSC of the SN areas was not
compared between field strengths, as differences in head positioning could alter the true
spatial overlap of said measurements. It would therefore be necessary to evaluate whether
head positioning introduced significant variability in the evaluated SN regions. A previous
study [70] investigated the repositioning effect between scans and observed no significant
differences in SN measurements. However, in that study, only the contrast variations with
head positioning were accounted for, since the different images were co-registered to a
common reference.
Another important issue in NM-MRI is head motion artefacts, which can be increased
due to clinical symptoms, especially in cases of PD, such as tremors and aggravated due to
the long duration of these sequences. Averaging images acquired at different positions may
result in a final image with diminished quality [51]. Although 3D sequences are associated
to higher SNR, they are typically more sensitive to motion. In this study, a 2D sequence
was applied, as these typically have shorter acquisition times, consequentially reducing the
potential for motion artefacts.
The SN area was measured in a single slice (middle slice), as opposed to evaluating
the whole SN volume, to reduce partial volume effects occurring in the outer portions due
to the thick slices that had to be used (2.5mm) to ensure sufficient SNR. In addition, 2D
segmentation of a single slice is simpler and faster and therefore more easily included in
clinic practice.
Additionally, even though the CR was not significantly different between field strengths,
CR at 1.5T was lower than at 3T introducing variability in the SN measurements. In
this study various sources of variability could have influenced the agreement of the SN
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measurements between field strengths. Nevertheless, the tested semi-automatic algorithm
revealed to be reliable at 1.5T.
This study has some limitations, namely the small sample size (12 patients), although
the number is not very different from other published NM-MRI studies (range 6-11 subjects)
[49, 51, 70] and the statistical tests were performed taking the sample size into account.
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Adaptation of the 1.5T NM-MRI sequence for
DBS patients
In order to evaluate whether Deep Brain Stimulation has any observable effect on the SN
area, it is necessary to develop a 1.5T NM-sensitive sequence that is not harmful to PD
patients with these systems implanted and is in compliance with all DBS-MRI conditions
- as mentioned in Section 2.3.2. Adding to this, the developed sequence must allow a
good visualization of the NM-SN area. In this chapter, the 1.5T sequence developed
to scan patients with implanted neurostimulators is presented and discussed. To assess
its feasibility in depicting the SN area, a comparison of the SN areas measured with a
semi-automated method was made between the referred 1.5T DBS sequence and the 1.5T
sequence previously validated in Chapter 3. In addition, the results obtained using the
1.5T DBS sequence in a patient after surgical placement of the DBS electrodes are also
presented.
4.1 Materials and Methods
4.1.1 Sample Description
This study included a cohort of six individuals (4 males and 2 females), with ages ranging
from 31 to 70 years (mean age: 43.5 ± 14.61 years). All subjects presented movement-
related disorders, with an undetermined diagnosis. Patients were recruited from the
Movement Disorders Unit of Hospital of Santa Maria-Lisbon.
The 1.5T DBS sequence was tested in a 60 years-old male PD patient, also included
in the previous study comparing NM-MRI sequences between field strengths - Chapter 3.
All examinations in this study were performed with the understanding and informed
consent of each subject.
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4.1.2 Imaging Protocol
In order to investigate the effects of DBS in the SN through NM-MR imaging of patients
with implanted neurostimulators, the 1.5T NM-MRI sequence previously developed and
validated in Chapter 3 had to be adapted to ensure that all DBS-related MRI limitations
were accounted for. The necessary adaptations made to the acquisition parameters are
discussed in 4.1.2.1.
Once again a comparative study was performed, this time between the two developed
1.5T NM-MRI sequences to investigate potential differences in segmentation reproducibility
and image contrast.
The acquisition parameters of the previously validated 1.5T sequence, from here on
designated as general sequence, were: TR/TE of 600/10ms; turbo factor of 3; FOV of
220×180 mm2; matrix size of 440×361 (pixel size of 0.50×0.50 mm2); slice thickness of
2.5mm with no gap; four averages; no PI and an acquisition time of 9:45 min.
The 1.5T sequence adapted to scan patients with implanted DBS systems, from here
on referred to as DBS sequence, had the following acquisition parameters: repetition
time/echo time of 750/9.5ms; turbo factor of 3; FOV of 220×189 mm2; matrix size of
440×375 (pixel size of 0.50×0.50mm2); slice thickness of 2.5mm with no gap; four averages;
PI with reduction factor of 1.5 and an acquisition time of 8:33 min.
All images were acquired using a T1–weighted FSE sequence with an 8-channel SENSE
head coil. All data were acquired with a 1.5T MRI system (Intera 1.5, Philips Medical
Systems, Best, Netherlands). Each subject underwent two scans – one for each 1.5T
sequence - in the MRI system, with both acquisitions being performed during the same
exam.
The PD patient was examined a single time with the 1.5T DBS sequence 3 months
after the implantation of the DBS system. These images were taken 5 months after the
initial scans with the 3T and general 1.5T NM-MRI sequences.
The sections were carefully set in the oblique axial plane perpendicular to the floor of
the fourth ventricle, starting from the posterior commissure to the inferior border of the
pons.
4.1.2.1 Analysis of the acquisition parameters
Patients with implanted neurostimulators can only be safely imaged with 1.5T MRI systems
and following certain conditions, as previously described in Section 2.3.2. The general 1.5T
sequence, which already fulfills a very important condition for DBS imaging – scanning with
a 1.5T MRI system, showed sufficient image contrast to enable SN segmentation. However,
the parameter B1+RMS has to be less than or equal to 2.0 µT in order to guarantee a safe
examination.
In order to ensure that B1+RMS stayed within safety limits, the repetition time (TR)
was increased, from 600ms to 750ms, considering that an increase in TR leads to a
reduction in the B1+RMS (1.98 µT). This TR increase can improve SNR as it increases
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the magnetization present in each voxel, but it also results in a longer scan acquisition.
Considering that the scan duration of the general sequence was already substantially long
(9:45 min), this added time increase, which resulted from the alteration of the TR, should
be compensated in order to diminish potential image artefacts and discomfort to the
patients. Thus, parallel imaging with SENSE was activated once again, like it was in the
original 3T sequence, with the same reduction factor of 1.5, enabling a faster acquisition
(8:33 min).
The pixel size was maintained the same (0.5x0.5) to ensure the same spatial resolution,
hence reducing variability sources between the two tested 1.5T sequences.
4.1.3 Imaging Analysis
All image processing was performed using the OsiriX program (Version Lite) [68].
In order to validate the developed 1.5T NM-MRI sequence optimized for patients with
implanted neurostimulators, the segmentation method that allows quantitative measure-
ment of the SN, previously described in Section 3.1.3.1, was applied to the SN on both
sides of the brain for every single patient. Considering the left and right regions-of-interest
of each image as independent regions, a total of 12 regions-of-interest were analyzed.
In the present study, the semi-automated segmentation method was performed three
times for each ROI in order to verify the feasibility of the algorithm. The repeated measures
were taken on different days to avoid biasing.
The CR was calculated after the Gaussian blur filter application using the method
previously described in Section 3.1.3.3. In order to assess CR differences between the 1.5T
NM-MRI sequences, ROI measurements were kept in the exact same position between
sequences.
For the DBS patient, a single measurement of the SN area was performed with the
semi-automatic algorithm for both sides of the brain. The CR was also measured with the
method described above.
4.1.4 Statistical Analysis
All statistical analyses were performed with the R software, version 3.3.3. (R Foundation
for Statistical Computing, Vienna, Austria), considering a p-value lower than 0.05 as
significant.
The Friedman test was applied to the three SN estimates of each ROI, in order to eval-
uate statistical differences within repeats. Additionally, a two-way random ICC evaluating
absolute agreement was performed to assess the algorithm’s repeatability. The ICC value
and its 95% CI were calculated and interpreted according to the criteria set by Landis and
Koch [73].
In order to assess the reproducibility of the segmented SN areas between the two tested
1.5T MRI sequences, the Wilcoxon signed rank test was applied to the corresponding
paired SN areas, as well as the Bland-Altman method.
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The Wilcoxon test was also used to investigate differences in the CR measured with
the two 1.5T NM-sensitive sequences.
4.2 Results
No significant differences were observed with the Friedman test for either 1.5T sequences
when comparing between the three repeated estimates of the SN area (Table 4.1). Moreover,
higher p-values were obtained with the general 1.5T sequence (p=0.8139) than with the
DBS-optimized sequence (p=0.7408).
The repeatability of the semi-automatic algorithm still needed to be assessed. To
that end, the ICC and CI of the repeated SN areas estimated with the semi-automatic
algorithm were calculated - Table 4.1. A high ICC was obtained for both 1.5T tested
sequences. The SN areas measured with the general sequence presented a slighter higher
and narrower CI (CIgeneral: 0.743 – 0.964, p<0.001) when compared to the 1.5T sequence
optimized to scan patients with implanted DBS systems (CIgeneral: 0.611 – 0.941, p<0.001).
Nevertheless, both sequences showed a substantial to almost perfect agreement between
repeated measures.
The segmented SN areas estimated with the semi-automatic algorithm showed excellent
test-retest reliability, justifying the usage from here on of a single sample of the areas
corresponding to the ROIs in the analysis.
The Wilcoxon test comparing the area of the same SN regions between sequences
revealed a non-significant difference (p-value=0.9097) between said estimates. Adding to
this, the analysis with Bland-Altman plot of the SN areas showed good agreement between
the semi-automatic measures obtained with the different sequences (Figure 4.1) with an
approximately null bias. Its limits of agreement ranged from -12.20 mm2 to 12.20 mm2,
which is narrower than the range obtained from the agreement between field strengths
(Figure 3.11).
When comparing the corresponding CRs between the 1.5T NM-MRI sequences, the
Wilcoxon test showed no significant difference with a p-value of 0.8438. The median CRs
of the 1.5T sequences were approximately the same (CRgeneral: 1.151; CRDBS : 1.150)
- Figure 4.2. Nevertheless, the range of the 1.5T general sequence [1.131 - 1.239] was
narrower than the 1.5T DBS sequence [1.094 - 1.267].
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Figure 4.1: Agreement analysis of SN areas between the two different 1.5T sequences –
general and optimized for DBS. The plot shows a null bias between the mean differences
and an agreement interval ranging from -12.20 mm2 to 12.20 mm2, with a 95% confidence
interval.
Figure 4.2: Dispersion of the SN CR after the Gaussian blur filter application, with the
general 1.5T sequence (left) and the DBS 1.5T sequence (right). No significant difference
was found between the 1.5T NM-MRI sequences.
47
CHAPTER 4. ADAPTATION OF THE 1.5T NM-MRI SEQUENCE FOR
DBS PATIENTS
Se
m
i-a
ut
om
at
ic
al
go
rit
hm
A
re
a
(m
m
2 )
M
ed
ia
n
(Q
1-
Q
3)
Fr
ie
dm
an
(p
-v
al
ue
)
IC
C
C
I
ge
ne
ra
l
Sa
m
pl
e
1
29
.5
(2
4.
1
-3
5.
5)
0.
81
39
0.
89
2
0.
74
3
-0
.9
64
Sa
m
pl
e
2
28
.7
(2
4.
8
-3
7.
3)
Sa
m
pl
e
3
31
.5
(2
5.
1
-3
7.
1)
D
BS
Sa
m
pl
e
1
28
.1
(2
0.
5
-3
6.
8)
0.
74
08
0.
82
5
0.
61
1
-0
.9
41
Sa
m
pl
e
2
29
.3
(2
1.
3
-3
6.
2)
Sa
m
pl
e
3
27
.5
(2
1.
3
-3
7.
6)
Ta
bl
e
4.
1:
IC
C
an
d
Fr
ie
dm
an
te
st
re
su
lts
of
th
e
co
m
pa
ris
on
be
tw
ee
n
th
e
th
re
e
re
pe
at
ed
SN
ar
ea
es
tim
at
es
ob
ta
in
ed
w
ith
th
e
se
m
i-a
ut
om
at
ic
se
gm
en
ta
tio
n
al
go
rit
hm
,f
or
th
e
ge
ne
ra
l1
.5
T
N
M
-M
R
Is
eq
ue
nc
e
de
ve
lo
pe
d
pr
ev
io
us
ly
an
d
1.
5T
N
M
-M
R
Is
eq
ue
nc
e
op
tim
iz
ed
to
sc
an
pa
tie
nt
es
w
ith
im
pl
an
te
d
D
BS
sy
st
em
s.
Q
1-
Q
3
re
pr
es
en
ts
th
e
ra
ng
e
of
th
e
bo
x
-f
ro
m
th
e
lo
we
rq
ua
rt
ile
(Q
1)
to
th
e
up
pe
rq
ua
rt
ile
(Q
3)
.I
C
C
:i
nt
ra
cl
as
s
co
rr
el
at
io
n
co
effi
ci
en
t,
95
%
C
I:
co
nfi
de
nc
e
in
te
rv
al
.
48
4.2. RESULTS
The obtained images and the SN areas, measured with the semi-automatic algorithm,
of the DBS patient are presented in Figure 4.3 and Table 4.2, respectively, jointly with the
corresponding results obtained previously with the 3T and general 1.5T NM-MRI sequence.
The right SN area measured in this case was substantially reduced when compared with
the measurements performed with the other NM-MRI sequences, in agreement with what
can be observed with the images. The left SN area is very similar to the corresponding SN
area obtained with the 1.5T general sequence and not much smaller in comparison with
the 3T sequence. However, despite presenting similar sizes, the spatial distribution of the
SN area observed in 4.3a appears to be slightly altered. The CR calculated with the 1.5T
DBS sequence was very similar, although slightly smaller (1.114) than the CR obtained
at 3T (1.123). The CR measured with the 1.5T general sequence was unexpectedly higher
than at 3T (Table 4.2), which must have been a statistical anomaly considering the CR
observations in Chapter 3.
a DBS sequence b general 1.5T sequence
c 3T sequence
Figure 4.3: Axial sections at the level of the midbrain showing the SN area of the same
patient, taken with three different NM-MRI sequences - 1.5T DBS sequence (a), 1.5T
general sequence (b) and 3T sequence (c). Image (a) was taken after surgical placement
of DBS electrodes.
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DBS general 1.5T 3T
Area (mm2) Right side 9.5 26.0 35.0Left side 31.2 32.3 40.1
CR 1.114 1.199 1.123
Table 4.2: SN areas of the same patient measured with the semi-automatic algorithm in
three different NM-MRI sequences - 3T and general 1.5T sequences in the same day and
DBS sequence after the surgical intervention.
4.3 Discussion
When evaluating the reliability of the semi-automated method between the two 1.5T NM-
MRI sequences, a simpler comparison than the one made in Chapter 3 was performed
measuring only the semi-automated areas. This decision was made due to the smaller
sample size of this study (6 subjects) and considering that the semi-automatic SN measures
showed good spatial agreement with the manual measures for both field strengths, even
though it was more likely to observe SN differences between field strengths.
The test-retest agreement (repeatability) of the semi-automated SN measures using
the 1.5T DBS sequence revealed a substantial to almost perfect agreement, as the general
1.5T did. Despite the agreement measured with the ICC was slightly smaller comparing
to the general 1.5T sequence, their similar results may indicate that the semi-automatic
algorithm is reproducible with the 1.5T DBS sequence. Additionally, the 1.5T general
sequence ICC results for the SN areas obtained in Chapter 3 were slightly worse, even
with a greater sample size.
The comparison between 1.5T sequences with the Bland-Altman method, showing a
null bias, indicates that, on average, the segmented areas have the same size. This was
a very positive result, especially considering the small sample size, and even though the
obtained range was narrower than the one obtained between field strengths, it was still
substantial. A few factors (differences in SNR, CR, and motion artifacts), some already
previously discussed in section 3.3, could have contributed to this wide range of agreement
between the SN areas.
Considering that no significant difference was observed between the CRs of the 1.5T
sequences and that their median values were very similar, it is likely that CR was not the
main factor to influence the variability of the SN areas. Still, the slightly wider range of
CR obtained with the DBS sequence may contribute, in part, to the SN area variability.
As it was previously discussed, the image contrast influences the delineation of the SN
area with the semi-automatic algorithm.
Once again, SNR evaluation could not be performed between the 1.5T sequences be-
cause PI was employed in one of the sequences. The 1.5T DBS sequence had to compensate
for the time increase that resulted from the necessary changes for examination.
In a previous study at 3T [51], it was demonstrated that GE sequences with MT
pulses can generate NM-sensitive images with improved contrast in comparison with FSE
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sequences with no additional MT pulse, since the latter sequence relies only on incidental
MT effects. Nevertheless, in this study, in order to carry out the clinic practice’s needs,
a FSE sequence was chosen to investigate feasibility of the semi-automatic segmentation
algorithm in 1.5T sequences befitting the necessary conditions to scan DBS patients. The
same group also investigated the specific absorption rate (SAR) for the two types of NM-
MRI sequences and observed a significant decrease in GE sequences [51]. Further studies
should compare the performance of these two types of sequences at 1.5T, considering not
only the SAR but also the B1+RMS which has been established as a more accurate measure
of potential heating, since it is not patient dependent and it does not vary according to the
model considered by each MRI manufacturer [39]. Future work should also compare the
performance of GE and FSE 1.5T NM-MRI sequences as biomarkers for early detection
of Parkinson’s disease and to differentiate between disease stages.
Considering a preliminary result of the 1.5T DBS NM-MRI sequence performed on
a patient with implanted neurostimulators, the SN area visualization does not appear
to be accurate. The right SN area was too small in comparison with the measurements
performed with the other NM-MRI sequences. It is difficult to assess whether this reduction
in the area is due to lower accuracy in the delineation of the SN associated to lower CR
associated to the sequence itself, the presence of the DBS electrodes or even other factors.
The study comparing the two 1.5T sequences does not appear to be consistent with this
patient. There was only one case in which the 1.5T DBS sequence provided poorer SN
visualization, nevertheless the study’s sample size was very small. In both comparisons
between sequences (Chapters 3 and 4), even though the SN areas revealed to have the
same size on average, the wide variability observed prevents reliable conclusions to be
inferred from a single sample. In order to assess potential effects of DBS therapeutic in
the NM-SN, the 1.5T DBS sequence should be tested with a big sample size.
A previous study [47] compared incidental MT effects in FSE sequences at 3T and 1.5T
and revealed that incidental MT effects are reduced at 1.5T. This reduction is likely to be
the reason for the observed reduction in CR and hence wider variability of the SN areas.
In addition, the applied TR increase in the DBS sequence can possibly be affecting the
T1-shortening effects, which would also contribute to a worse delineation of the SN. Future
work should test if different TRs influence the SN delineation and how other parameters,
such as reducing the Turbo factor, could be managed in order to optimize the 1.5T DBS
sequence. Another possible source for the reduced contrast observed with the DBS patient
could be the presence of the implanted electrodes (Figure 4.4). The electrodes could
potentially alter the homogeneity of the magnetic field and hence influence the resulting
image contrast.
Finally, another important factor to be considered is the variability related to head
positioning and slice orientation. This examination was performed on a different day,
unlike the images taken for the other two studies, which were either at least on the same
day or during the same examination. As previously discussed, head positioning may
not have much influence on the image contrast as demonstrated in [70]. However, the
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Figure 4.4: Axial section at the level of the upper midbrain of the DBS patient. The
left DBS electrode is still visible in this slice, which is adjacent to the slice chosen for SN
measurements. These slices are only distanced 2.5mm - the chosen slice thickness.
repositioning effect is likely to be influencing our segmentation, since it is performed in a
single slice. In the future it would be important to carry out a study that evaluates the
area variability associated with alterations in slice angulation and invest in a 3D sequence
and segmentation method in order to reduce the referred effect.
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Imaging Study of therapeutic effects on PD
patients
PD symptoms are very incapacitating but fortunately, through therapeutics, such as
medication or surgery, such symptoms can be eased. Recently many studies have been
assessing the application of NM-MRI as a diagnostic biomarker for PD and also as a means
to further investigate the disease. In order to investigate potential effects of therapeutics in
the SN progression, in this chapter are presented the results of a study on the medication
effects in the SN using NM-MRI. Using a 3T NM-MRI sequence, a comparison was made
between SN areas of a PD de novo group taken before and after two months of initiating
the medication.
5.1 Review on the dopamine metabolism
Parkinson’s disease symptoms can be significantly modified with medication, mainly with
L-dopa or dopamine agonists [76]. Even though both drugs contribute to an alleviation
of symptoms, its consequences on the dopamine metabolism and in turn on the course of
PD, are still unclear. Investigating the influence of the medication on the SN NM signal
could contribute to a better understanding of the effects of this therapeutical intervention
in PD.
As previously described, in PD there is a loss of pigmented dopaminergic neurons of the
SN, which produce a chemical - Dopamine (DA) – relevant in the control of motor activity.
DA can be transformed trough oxidation into an intermediate product - DA-quinone,
usually chelating metals, especially iron. These DA derivatives are then transformed into
aminochrome, which is a precursor for the neuronal pigment neuromelanin. The role of
iron in the NM production is essential, seeing that it protects the cell from oxidative stress
[77] (Figure 5.1).
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Figure 5.1: Dopamine metabolism on a DAergic neuron. NM is built out of DA oxidation
products and chelates iron, staying confined in cytoplasmatic vesicles. When DA is released
in the presynaptic DAergic neuron, auto-oxidation or MAO of DA can contribute to cell
damage. There are several other DA-related mechanisms that may lead to neuronal death.
Adapted from [77].
L-dopa is a precursor for endogenous DA production in the presynaptic dopaminergic
neurons of the striatum. During an initial stage of the L-dopa administration, there is a
regenerator and protective effect, alleviating the symptoms [78]. However, over time, “the
capacity of the nigrostriatal DA system to store and release dopamine is lost” [76], leading
to motor complications.
It is believed that L-dopa contributes to oxidative stress, thereby accelerating the
progression of PD. If there were a dysfunction in storing DA, the excessive released
dopamine could lead to free radicals formation through MonoAmine Oxidation (MAO)
and consequently, oxidative stress [78] (Figure 5.1). Therefore, considering the long-term
consequences of L-dopa, dopamine agonists have been increasingly used as an alternative
in alleviating the clinical features of PD [76].
Dopamine agonists can influence postsynaptic DA receptors on the striatum and presy-
naptic receptors in the SN. Noting that dopamine agonists (exogenous DA) do not depend
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on the capacities of the nigrostriatal neurons, this medication may prevent free radical
formation as a result of endogenous DA metabolism [76]. In addition, a study demon-
strated that SN neurons show comparatively low MAO presence when compared with
other neurons [79].
5.2 Materials and Methods
5.2.1 Sample Description
The present study included a cohort of six individuals (3 males and 3 females), with ages
ranging from 46 to 82 years (mean age: 64.2 ± 14.3 years). All subjects were diagnosed
with Parkinson’s disease by a movement disorders specialist according to the PD UK Brain
Bank criteria [66] and were rated using the UPDRS. Patients were recruited from the
Movement Disorders Unit of Hospital of Santa Maria-Lisbon.
The PD patients, denominated as PD de novo in this study, were included at the time
of their first diagnosis if they were not taking any anti-Parkinson medication and were
considered to be at an initial stage of the disease. It was considered early stage of the
disease if the patients had been diagnosed within 6 months of the first symptoms.
The examinations were performed with the understanding and informed consent of
each subject. These images had already been used in a previous work [80].
5.2.2 Imaging Protocol
In order to assess potential effects of pharmacological medication on the signal of NM-SN
in patients first receiving medication, the PD group underwent two MRI acquisitions over
time. The first acquisition was performed at the time of the diagnosis, before the patients
took any anti-Parkinson medication, and the second scan was performed two months after
initiating medication. All patients were treated with the dopamine agonist - Ropinirole -,
initiating with a dose of 2mg/d, 4mg/d and 6mg/d, respectively, in the first 3 weeks and
continuing the treatment with a stable dose of 6mg/day.
All images were collected using a 3T MRI (Achieva 3.0, Philips Medical Systems, Best,
Netherlands) system with a 32-channel SENSE head coil. The used MRI sequence was a
T1–weighted FSE; the same as the 3T sequence described in 3.1.2. To obtain the desired
images of the substantia nigra, the sections were carefully set in the oblique axial plane
perpendicular to the floor of the fourth ventricle, ensuring coverage from the posterior
commissure to the inferior border of the pons.
5.2.3 Imaging Analysis
The segmentation algorithm used in this study for the measurements of the SN areas was
the same as the previously described in Section 3.1.3.1.
55
CHAPTER 5. IMAGING STUDY OF THERAPEUTIC EFFECTS ON PD
PATIENTS
The same procedure was used for all images, which included firstly the application of the
Gaussian blur filter and then the segmentation using the Confidence algorithm, followed
by the application of Brush Closing to remove any holes in the delineated ROI. A single
SN area estimate was calculated for every ROI, using the semi-automatic segmentation
algorithm. The estimates for the different scans – at the time of diagnosis and two months
after initiating medication – were performed on different days. The measured areas of the
SN were recorded for both sides of the brain.
5.2.4 Statistical Analysis
All statistical analyses were performed with the R software, version 3.3.3. (R Foundation
for Statistical Computing, Vienna, Austria), considering a p-value lower than 0.05 as
significant.
In order to assess potential effects of anti-Parkinson medication in the SN area, the
Wilcoxon signed rank test was applied to the corresponding paired SN areas – estimated
before and after medication.
The Wilcoxon test was also used to investigate differences in the UPDRS scores (part
III, corresponding to motor examination, and total) rated before and after the initiation of
medication. However, only five subjects were accounted for this comparison, considering
that one of the subjects dropped out of the study and his UPDRS score after two months
of initiating medication was not evaluated.
5.3 Results
No significant differences (p-value=0.1514) were detected when comparing the SN areas
determined at the time of diagnosis and after 2 months of initiating medication, using
the Wilcoxon pair-wised comparison. However, the dispersion of the SN areas measured
before and after medication may suggest a tendency for the median SN area to increase
after medication (Figure 5.2).
The Wilcoxon comparison applied to the UPDRS scores (mean score ± standard devi-
ation) - part III and total - evaluated before (UPDRSIII : 38±15; UPDRSTotal: 58±31)
and after medication (UPDRSIII : 40±12; UPDRSTotal: 62±27) showed no significant
differences for either UPDRSIII (p-value=0.625) and UPDRSTotal (p-value=0.5879).
5.4 Discussion
Segmentation of the SN using T1-weighted FSE NM-sensitive MRI as an accurate diag-
nostic tool for discrimination of Parkinson’s disease patients from healthy subjects [40]
has been increasingly applied. Even more, investigating potential differences in the SN
hyper-intense area can contribute to a better understanding of the underlying mechanisms
in PD.
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Figure 5.2: Box and whisker plot of the Substantia nigra areas estimated from the NM-MR
images taken before and after medication. No significant differences were found, although
the median SN area was increased after 2 months of medication (27.0 mm2) compared to
at the time of diagnosis (23.2 mm2).
Recently, a study by Hatano et al. [81] reported a significant reduction in the measured
SN area in PD patients displaying motor complications induced by L-dopa medication.
However, PD patients with motor complications also had longer disease durations (10±3
years versus 5±3; mean ± standard deviation). In latter stages the significant reduction of
neuromelanin can possibly no longer be compensated by the administered dopamine and
so the signal is reduced. Therefore, this study intended to assess potential changes of the
NM MR signal in drug naïve patients at an initial stage of the disease.
The dopamine agonist Ropinirole was chosen as the administered pharmacological
medication, considering that DA agonists, unlike L-dopa, are believed to have a more
protective and healing effect, preventing further motor complications over time. Thus, this
study investigated potential effects on the signal of NM in the SN in patients first receiving
DA agonists.
Although the Wilcoxon test showed no significant difference between the SN areas
estimated before and after medication, the median SN area tended to be increased after
medication (Figure 5.2). This finding may be related to the increase of neuromelanin,
related to the dopamine therapy.
Ropinirole has a selective activity at D2 and D3 dopamine receptors, which are localized
postsynaptically on striatal neurons and presynaptically in the SN [82]. Considering that
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NM is derived from DA oxidation products in the presynaptic dopaminergic neurons of
the SN and that the selected dopamine agonist leads to activation of these dopamine
receptors, the administration of this medication could explain the increase on the NM-SN
hyper-intense MR signal.
In spite of the tendency for the SN area to increase, both UPDRS values (motor-related
and total) did not show a significant change. In fact, the overall median UPDRS scores
even revealed a slight increase. However, it is common for the UPDRS scores to increase
even when the patients are taking ant-Parkinson medication and, specifically at an earlier
stage of pharmacological treatment, their response to the treatment is usually slow and
not always positive. Therefore, studying the influence of medication on the SN MR signal
only after two months of initiating it, may have been a period too small for significant
differences to be observed and, in the future, a positive response by the patients should
be guaranteed.
Furthermore, this study was performed with a very small sample size (6 subjects) and
no significant differences on the measured SN areas caused by medication were observed,
only a slight tendency. Therefore, further studies, with larger samples, are needed to
corroborate these findings.
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6.1 Conclusions
The main goal of the present work was to obtain a 1.5T NM-sensitive MRI sequence that
enables an accurate measurement of the NM-SN area of patients with implanted Deep
Brain Stimulation systems. To achieve that, firstly, being aware of how MRI parameters
interact with each other and influence the resulting image, the currently used 3T NM-
MRI sequence was adapted so it could be used at a 1.5T MRI system, providing images
whose quality sufficed for an accurate SN segmentation. On a second phase, the 1.5T
NM-MRI sequence was adapted to guarantee the necessary conditions to scan patients
with implanted neurostimulators, presenting a B1+RMS of 1.98 µT. In addition, in order to
validate the developed NM-MRI sequences, a semi-automatic algorithm optimized for SN
segmentation was evaluated resorting to a test-retest agreement analysis. The repeatability
of the algorithm revealed to have a substantial to almost perfect agreement, for all tested
sequences. The Bland-Altman method showed a small bias between field strengths, even
though the CR tended to be lower at 1.5T, suggesting a good agreement, on average,
between the SN areas. The DBS sequence presented very similar results, revealing a null
bias between the 1.5T SN measures. Despite the good agreement, on average, observed for
both comparisons, wide limits of agreement, which could have been influenced by a few
factors (differences in SNR, CR, head positioning and motion artefacts), were obtained. In
conclusion, this study not only validated the reliability of the semi-automatic segmentation
algorithm, but it also presented a feasible 1.5T NM-MRI sequence that allows correct SN
delineation. This sequence could potentially enable the assessment of disease progression
on these particular cases and lead to a further understanding on PD and on how DBS
alters the course of the disease. Furthermore, the 1.5T NM-MRI sequence could be used
as an alternative tool for PD assessment when examinations with the 3T MRI scanner is
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not a possibility.
Ideally, the 1.5T NM-MRI sequence adapted to scan patients with implanted DBS
systems, which enables the measurement of the SN, would have been used to investigate
potential effects of this therapeutic in the signal of the NM in the SN of said PD patients.
However, the reduced access of the clinic to PD patients scheduled for surgical intervention
during the period of this work as well as medical and technical complications regarding
those patients prevented the execution of this specific study. Still, the 1.5T DBS sequence
was used to scan a single patient after surgical placement of the neurostimulators. The
reduced contrast of the image led to a discussion on the factors which could be causing
that and prevented to formulate hypothesis on the potential effects of DBS therapeutic in
the NM-SN. Future work should be carried out to improve the CR of the 1.5T sequence
so that studying the effects of DBS on the NM-SN can become feasible in the future.
Instead, the study performed with PD de novo subjects was carried out as an alter-
native for investigating potential effects of PD therapeutics, specifically pharmacological
medication, on the NM-SN signal obtained from neuromelanin-sensitive MRI sequences. In
this study, although no significant differences were observed, NM-MR imaging revealed a
tendency for the SN area to increase in PD de Novo patients after a period of two months
of anti-Parkinson medication. This finding may suggest a change in MR signal of the
NM related to the increase of dopamine, associated with the administered DA agonists.
Nevertheless, these results need to be duplicated in further studies with larger sample
sizes. All in all, therapeutic effects in the NM-SN of PD patients opens a path to better
understand pharmacological and clinical effects as well as provide a method for treatment
evaluation.
At the moment, two articles are being prepared for publishing. One article focus on
the feasibility of SN measurements using a 1.5T NM-MRI sequence, adapted in this work,
as a method for evaluating DBS effects in the SN of PD patients. The other publication is
a short letter which presents the results about the NM-SN alteration under the influence
of medication in PD patients.
6.2 Suggestions for Future Work
Along this work, SN area comparisons between sequences were performed. Despite the
obtained good agreement, the range of agreement was wide and such could have originated
from various sources. Some were studied in this work and others discussed based on
previous performed studies. It was not possible to investigate SNR differences between
the sequences because only the final averaged images were available with the scanner and
in both comparisons, PI was only employed in of the sequences. Nevertheless, this subject
should be investigated, if possible between the 3T NM-MRI sequence and the 1.5T DBS
sequence.
Regarding the possibility of using the 1.5T NM-MRI sequence as a diagnostic tool
for PD, it is of extreme necessity to carry out a case-control study that investigates the
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performance of the sequence in detecting differences in the SN for early detection of PD
and to differentiate between disease stages. Also, if possible it would be important to
perform this study with a bigger sample size.
With respect to the analysis of potential PD therapeutic effects in the SN, which
revealed a very interesting result with a tendency for the SN area to be increased as a
result of pharmacological medication, it is important to reproduce these results, in the
future, with a bigger sample size. In addition, it would be interesting to investigate the iron
relation to the neuromelanin formation, as a result of the dopamine oxidation products,
and its effect in NM-MRI.
61

Bibliography
[1] M. A. Brown and R. C. Semelka. MRI: basic principles and applications. 3rd ed.
Hoboken, New Jersey: John Wiley & Sons, 2003.
[2] Elster LLC. Questions and Answers in MRI: Spin Echo Variations. Accessed:
2017-03-24. 2017. url: http://www.mriquestions.com/se-vs-multi-se-vs-
fse.html.
[3] Elster LLC. Questions and Answers in MRI: Fast spin-echo. Accessed: 2017-08-27.
2017. url: http://mri-q.com/what-is-fsetse.html.
[4] Elster LLC. Questions and Answers in MRI: GRE vs SE. Accessed: 2017-03-24.
2017. url: http://www.mriquestions.com/gre-vs-se.html.
[5] Elster LLC. Questions and Answers in MRI: Image Contrast. Accessed: 2017-09-15.
2017. url: http://mriquestions.com/image-contrast-trte.html.
[6] G. Ayano. “Parkinson’s Disease: A Concise Overview of Etiology, Epidemiology,
Diagnosis, Comorbidity and Management.” In: Journal of Neurological Disorders 4.6
(2016), pp. 1–6.
[7] S. von Campenhausen, B. Bornschein, R. Wick, K. Bötzel, C. Sampaio, W. Poewe,
W. Oertel, U. Siebert, K. Berger, and R. Dodel. “Prevalence and incidence of
Parkinson’s disease in Europe.” In: European Neuropsychopharmacology. Vol. 15. 4.
Elsevier, 2005, pp. 473–490.
[8] C. F. M. Souza, H. C. P. Almeida, J. Sousa, P. Costa, Y. S. S. Silveira, and J. C. L.
Bezerra. “A doença de Parkinson e o processo de envelhecimento motor: uma revisão
de literatura.” In: Rev Neurocienc 19.4 (2011), pp. 718–723.
[9] S.-Y. Chen and S.-T. Tsai. “The epidemiology of Parkinson’s disease.” In: Tzu Chi
Medical Journal. Vol. 22. 2. Elsevier, 2010, pp. 73–81.
[10] G. E. Alexander. “Biology of Parkinson’s disease: pathogenesis and pathophysiology
of a multisystem neurodegenerative disorder.” In: Dialogues in Clinical Neuroscience.
Vol. 6. 3. Les Laboratoires Servier, 2004, pp. 259–280.
[11] Mayfield Clinic. Parkinson’s Disease. Accessed: 2017-02-02. 2016. url: http:
//www.mayfieldclinic.com/PE-PD.htm.
[12] R. F. Pfeiffer, Z. K. Wszolek, and M. Ebadi. Parkinson’s Disease. 2nd ed. New
York: CRC Press, 2013.
63
BIBLIOGRAPHY
[13] Brainstem III: The Midbrain (Organization of the Central Nervous System) Part
1. Accessed: 2017-09-19. url: http://what- when- how.com/neuroscience/
brainstem - iii - the - midbrain - organization - of - the - central - nervous -
system-part-1/.
[14] F. Blandini, G. Nappi, C. Tassorelli, and E. Martignoni. “Functional changes of the
basal ganglia circuitry in Parkinson’s disease.” In: Progress in Neurobiology. Vol. 62.
1. Elsevier, 2000, pp. 63–88.
[15] National Parkinson Foundation. What Is Parkinsons? Accessed: 2017-02-03. 2017.
url: http : / / www . parkinson . org / understanding - parkinsons / what - is -
parkinsons.
[16] L. C. Triarhou. “Dopamine and Parkinson’s Disease.” In: Madame Curie Bioscience
Database. Landes Bioscience, 2013.
[17] C. G. Goetz, B. C. Tilley, S. R. Shaftman, G. T. Stebbins, S. Fahn, P. Martinez-
Martin, W. Poewe, C. Sampaio, M. B. Stern, R. Dodel, et al. “Movement Disorder
Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-
UPDRS): Scale presentation and clinimetric testing results.” In: Movement Disorders.
Vol. 23. 15. John Wiley & Sons, Inc, 2008, pp. 2129–2170.
[18] R. Katzenschlager and A. J. Lees. “Treatment of Parkinson’s disease: levodopa as
the first choice.” In: Journal of Neurology. Vol. 249. Springer, 2002, pp. II19–II24.
[19] L. Zecca, R. Fariello, P. Riederer, D. Sulzer, A. Gatti, and D. Tampellini. “The
absolute concentration of nigral neuromelanin, assayed by a new sensitive method,
increases throughout the life and is dramatically decreased in Parkinson’s disease.”
In: FEBS Letters. Vol. 510. 3. John Wiley & Sons, Inc, 2002, pp. 216–220.
[20] F. A. Zucca, E. Basso, F. A. Cupaioli, E. Ferrari, D. Sulzer, L. Casella, and L.
Zecca. “Neuromelanin of the human substantia nigra: an update.” In: Neurotoxicity
Research. Vol. 25. 1. Springer, 2014, pp. 13–23.
[21] Neuroloss. Parkinson’s disease. Accessed: 2017-08-17. url: https://neuroloss.
wordpress.com/parkinsons-disease/.
[22] D. Dexter, F. Wells, A. Lee, F Agid, Y Agid, P Jenner, and C. Marsden. “Increased
nigral iron content and alterations in other metal ions occurring in brain in Parkin-
son’s disease.” In: Journal of Neurochemistry. Vol. 52. 6. John Wiley & Sons, Inc,
1989, pp. 1830–1836.
[23] L. Zecca, A. Stroppolo, A. Gatti, D. Tampellini, M. Toscani, M. Gallorini, G. Giaveri,
P. Arosio, P. Santambrogio, R. G. Fariello, et al. “The role of iron and copper
molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during
aging.” In: Proceedings of the National Academy of Sciences of the United States of
America 101.26 (2004), pp. 9843–9848.
64
BIBLIOGRAPHY
[24] P. Limousin, P. Krack, P. Pollak, A. Benazzouz, C. Ardouin, D. Hoffmann, and A.-L.
Benabid. “Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s
disease.” In: New England Journal of Medicine 339.16 (1998), pp. 1105–1111.
[25] A. O. Ceballos-Baumann. “Functional imaging in Parkinson’s disease: activation
studies with PET, fMRI and SPECT.” In: Journal of Neurology. Vol. 250. 1.
Springer, 2003, pp. I15–23.
[26] Medtronic. MRI guidelines for Medtronic deep brain stimulation systems. 2015.
[27] D. B. Lester, T. D. Rogers, and C. D. Blaha. “Neuronal pathways involved in deep
brain stimulation of the subthalamic nucleus for treatment of Parkinson’s disease.”
In: Conference proceedings : 31st Annual International Conference of the IEEE
Engineering in Medicine and Biology Society. 2009, pp. 3302–3305.
[28] J. Kahan, A. Papadaki, M. White, L. Mancini, T. Yousry, L. Zrinzo, P. Limousin,
M. Hariz, T. Foltynie, and J. Thornton. “The safety of using body-transmit MRI
in patients with implanted deep brain stimulation devices.” In: PLOS ONE 10.6
(2015), pp. 1–20.
[29] S. A. Mohsin, N. M. Sheikh, and U. Saeed. “MRI induced heating of deep brain
stimulation leads: Effect of the air-tissue interface.” In: Progress In Electromagnetics
Research 83 (2008), pp. 81–91.
[30] M. F. Dempsey, B. Condon, and D. M. Hadley. “Investigation of the factors respon-
sible for burns during MRI.” In: Journal of Magnetic Resonance Imaging. Vol. 13.
4. John Wiley & Sons, Inc, 2001, pp. 627–631.
[31] J. M. Henderson, J. Tkach, M. Phillips, K. Baker, F. G. Shellock, and A. R. Rezai.
“Permanent neurological deficit related to magnetic resonance imaging in a patient
with implanted deep brain stimulation electrodes for Parkinson’s disease: case re-
port.” In: Neurosurgery 57.5 (2005).
[32] J. Spiegel, G. Fuss, M. Backens, W. Reith, T. Magnus, G. Becker, J.-R. Moringlane,
and U. Dillmann. “Transient dystonia following magnetic resonance imaging in a
patient with deep brain stimulation electrodes for the treatment of Parkinson disease:
Case report.” In: Journal of Neurosurgery 99.4 (2003), pp. 772–774.
[33] D. Dormont, D Seidenwurm, D. Galanaud, P Cornu, J Yelnik, and E Bardinet.
“Neuroimaging and deep brain stimulation.” In: American Journal of Neuroradiology
31.1 (2010), pp. 15–23.
[34] A. R. Rezai, A. M. Lozano, A. P. Crawley, M. L. Joy, K. D. Davis, C. L. Kwan, J. O.
Dostrovsky, R. R. Tasker, and D. J. Mikulis. “Thalamic stimulation and functional
magnetic resonance imaging: localization of cortical and subcortical activation with
implanted electrodes: technical note.” In: Journal of Neurosurgery 90.3 (1999),
pp. 583–590.
65
BIBLIOGRAPHY
[35] P. S. Larson, R. M. Richardson, P. A. Starr, and A. J. Martin. “Magnetic reso-
nance imaging of implanted deep brain stimulators: experience in a large series.” In:
Stereotactic and Functional Neurosurgery 86.2 (2008), pp. 92–100.
[36] R. Jason Stafford. Physics of MRI Safety. PowerPoint slides. Accessed: 2017-09-15.
2011. url: http://www.aapm.org/meetings/amos2/pdf/59-17207-59975-
979.pdf.
[37] William Faulkner, B.S., R.T. New MRI Safety Labels and Devices. B1+rms as a
Condition of Use. Accessed: 2017-05-02. 2016. url: http://www.ismrm.org/
smrt/E-Signals/2016FEBRUARY/eSig_5_1_hot_2.htm.
[38] Medtronic. 3T Labeling B1+RMS . 2016.
[39] T. O. Woods. “Standards for medical devices in MRI: present and future.” In:
Journal of Magnetic Resonance Imaging. Vol. 26. 5. John Wiley & Sons, Inc, 2007,
pp. 1186–1189.
[40] M. Sasaki, E. Shibata, K. Tohyama, J. Takahashi, K. Otsuka, K. Tsuchiya, S. Taka-
hashi, S. Ehara, Y. Terayama, and A. Sakai. “Neuromelanin magnetic resonance
imaging of locus ceruleus and substantia nigra in Parkinson’s disease.” In: Neurore-
port 17.11 (2006), pp. 1215–1218.
[41] S. Kitao, E. Matsusue, S. Fujii, F. Miyoshi, T. Kaminou, S. Kato, H. Ito, and T.
Ogawa. “Correlation between pathology and neuromelanin MR imaging in Parkin-
son’s disease and dementia with Lewy bodies.” In: Neuroradiology 55.8 (2013),
pp. 947–953.
[42] M. Sasaki, E. Shibata, K. Kudo, and K. Tohyama. “Neuromelanin-sensitive MRI.”
In: Clinical Neuroradiology 18.3 (2008), pp. 147–153.
[43] S. Reimão and J. J. Ferreira. “Neuromelanin MR imaging in Parkinson’s disease.”
In: The CNS Journal. Vol. 2. 1. Oruen Ltd, 2016.
[44] H. Oikawa, M. Sasaki, Y. Tamakawa, S. Ehara, and K. Tohyama. “The substantia
nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion
time inversion-recovery MR findings.” In: American Journal of Neuroradiology 23.10
(2002), pp. 1747–1756.
[45] C. Ohtsuka, M. Sasaki, K. Konno, M. Koide, K. Kato, J. Takahashi, S. Takahashi,
K. Kudo, F. Yamashita, and Y. Terayama. “Changes in substantia nigra and
locus coeruleus in patients with early-stage Parkinson’s disease using neuromelanin-
sensitive MR imaging.” In: vol. 541. Elsevier Ireland Ltd, 2013, pp. 93–98.
[46] J. P. Wansapura, S. K. Holland, R. S. Dunn, and W. S. Ball. “NMR relaxation
times in the human brain at 3.0 tesla.” In: Journal of Magnetic Resonance Imaging.
Vol. 9. 4. John Wiley & Sons, Inc, 1999, pp. 531–538.
66
BIBLIOGRAPHY
[47] Y. Chang, S. J. Bae, Y. J. Lee, M. J. Hwang, S. H. Lee, J. Lee, S. K. Lee, and
S. Woo. “Incidental magnetization transfer effects in multislice brain MRI at 3.0 T.”
In: Journal of Magnetic Resonance Imaging. Vol. 25. 4. John Wiley & Sons, Inc,
2007, pp. 862–865.
[48] D. W. McRobbie, E. A. Moore, M. J. Graves, and M. R. Prince. MRI: from picture
to proton. 2nd ed. New York: Cambridge University Press, 2003, pp. 0–393.
[49] T. Nakane, T. Nihashi, H. Kawai, and S. Naganawa. “Visualization of neuromelanin
in the Substantia nigra and locus ceruleus at 1.5 T using a 3D-gradient echo sequence
with magnetization transfer contrast.” In: Magnetic Resonance in Medical Sciences
7.4 (2008), pp. 205–210.
[50] S. Naganawa, T. Koshikawa, K. Sato, T. Katagiri, T. Mimura, T. Ishigaki, and I. Aoki.
“Pseudostenosis of the internal carotid artery in 3D time-of-flight MR angiography:
effects of a magnetization transfer contrast pulse and metallic material.” In: European
Radiology. Vol. 13. 10. Springer, 2003, pp. 2298–2303.
[51] X. Chen, D. E. Huddleston, J. Langley, S. Ahn, C. J. Barnum, S. A. Factor, A. I.
Levey, and X. Hu. “Simultaneous imaging of locus coeruleus and substantia nigra
with a quantitative neuromelanin MRI approach.” In: Magnetic Resonance Imaging.
Vol. 32. 10. Elsevier, 2014, pp. 1301–1306.
[52] P. Melki and R. Mulkern. “Magnetization transfer effects in multislice RARE se-
quences.” In: Magnetic Resonance in Medicine. Vol. 24. 1. John Wiley & Sons, Inc,
1992, pp. 189–195.
[53] J. P. Tavares. “Otimização de Protocolos de Aquisição de Imagens de Ressonância
Magnética Sensíveis à Concentração de Neuromelanina.” Master’s thesis. Faculty of
Sciences and Technology, NOVA University of Lisbon, 2015.
[54] S. T. Schwarz, T. Rittman, V. Gontu, P. S. Morgan, N. Bajaj, and D. P. Auer.
“T1-Weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson’s
disease.” In: Movement Disorders. Vol. 26. 9. John Wiley & Sons, Inc, 2011,
pp. 1633–1638.
[55] K. Ogisu, K. Kudo, M. Sasaki, K. Sakushima, I. Yabe, H. Sasaki, S. Terae, M.
Nakanishi, and H. Shirato. “3D neuromelanin-sensitive magnetic resonance imaging
with semi-automated volume measurement of the substantia nigra pars compacta
for diagnosis of Parkinson’s disease.” In: Neuroradiology 55.6 (2013), pp. 719–724.
[56] I. Natário. Probabilidades e Estatística. 2012.
[57] D. J. Sheskin. Handbook of parametric and nonparametric statistical procedures.
3rd ed. Boca Raton, Florida: CRC Press, 2003.
[58] V. Bewick, L. Cheek, and J. Ball. “Statistics review 10: further nonparametric
methods.” In: Critical Care. Vol. 8. 3. BioMed Central Ltd, 2004, pp. 196–199.
67
BIBLIOGRAPHY
[59] E. Whitley and J. Ball. “Statistics review 6: Nonparametric methods.” In: Critical
Care. Vol. 6. 6. BioMed Central Ltd, 2002, pp. 509–513.
[60] T. K. Koo and M. Y. Li. “A guideline of selecting and reporting intraclass correlation
coefficients for reliability research.” In: Journal of Chiropractic Medicine. Vol. 15. 2.
Elsevier, 2016, pp. 155–163.
[61] K. O. McGraw and S. P. Wong. “Forming inferences about some intraclass corre-
lation coefficients.” In: Psychological Methods. Vol. 1. 1. American Psychological
Association, 1996, pp. 30–46.
[62] J. M. Bland and D. Altman. “Statistical methods for assessing agreement between
two methods of clinical measurement.” In: The Lancet. Vol. 327. 8476. Elsevier,
1986, pp. 307–310.
[63] D. Giavarina. “Understanding Bland Altman analysis.” In: Biochemia Medica 25.2
(2015), pp. 141–151.
[64] N. G. Baikoussis, E. Apostolakis, N. A. Papakonstantinou, I. Sarantitis, and D.
Dougenis. “Safety of magnetic resonance imaging in patients with implanted cardiac
prostheses and metallic cardiovascular electronic devices.” In: The Annals of Thoracic
Surgery. Vol. 91. 6. Elsevier, 2011, pp. 2006–2011.
[65] A. M. Ferreira, F. Costa, A. Tralhão, H. Marques, N. Cardim, and P. Adragão.
“MRI-conditional pacemakers: current perspectives.” In: Medical Devices: Evidence
and Research. Vol. 7. Dove Medical Press Ltd, 2014, pp. 115–124.
[66] A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees. “Accuracy of clinical diagnosis
of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases.” In:
Journal of Neurology, Neurosurgery & Psychiatry 55.3 (1992), pp. 181–184.
[67] D. J. Larkman and R. G. Nunes. “Parallel magnetic resonance imaging.” In: Physics
in Medicine & Biology. Vol. 52. 7. IOP Publishing Ltd, 2007, R15–R55.
[68] A. Rosset, L. Spadola, and O. Ratib. “OsiriX: an open-source software for navigating
in multidimensional DICOM images.” In: Journal of Digital Imaging. Vol. 17. 3.
Springer, 2004, pp. 205–216.
[69] M. Fabbri, S. Reimão, M. Carvalho, R. G. Nunes, D. Abreu, L. C. Guedes, R. Bouça,
P. P. Lobo, C. Godinho, M. Coelho, et al. “Substantia Nigra Neuromelanin as an
Imaging Biomarker of Disease Progression in Parkinson’s Disease.” In: Journal of
Parkinson’s Disease 7.3 (2017), pp. 491–501.
[70] J. Langley, D. E. Huddleston, C. J. Liu, and X. Hu. “Reproducibility of locus
coeruleus and substantia nigra imaging with neuromelanin sensitive MRI.” In: Mag-
netic Resonance Materials in Physics, Biology and Medicine. Vol. 30. 2. Springer,
2017, pp. 121–125.
68
BIBLIOGRAPHY
[71] M. Carvalho. “Estudo Imagiológico em Ressonância Magnética de doentes com
Doença de Parkinson Late Stage.” Master’s thesis. Faculty of Sciences and Technol-
ogy, NOVA University of Lisbon, 2016.
[72] M. Deeley, A Chen, R Datteri, J. Noble, A. Cmelak, E. Donnelly, A. Malcolm,
L. Moretti, J Jaboin, K Niermann, et al. “Comparison of manual and automatic
segmentation methods for brain structures in the presence of space-occupying lesions:
a multi-expert study.” In: Physics in Medicine & Biology 56.14 (2011), pp. 4557–77.
[73] J. R. Landis and G. G. Koch. “The measurement of observer agreement for categorical
data.” In: Biometrics. Vol. 33. 1. International Biometric Society, 1977, pp. 159–
174.
[74] J. L. Fleiss, B. Levin, and M. C. Paik. Statistical methods for rates and proportions.
3rd ed. New York: John Wiley & Sons, Inc, 2013.
[75] S. B. Reeder, B. J. Wintersperger, O. Dietrich, T. Lanz, A. Greiser, M. F. Reiser,
G. M. Glazer, and S. O. Schoenberg. “Practical approaches to the evaluation of
signal-to-noise ratio performance with parallel imaging: Application with cardiac
imaging and a 32-channel cardiac coil.” In: Magnetic Resonance in Medicine. Vol. 54.
3. John Wiley & Sons, Inc, 2005, pp. 748–754.
[76] M. M. Goldenberg. “Medical management of Parkinson’s disease.” In: Pharmacy
and Therapeutics 33.10 (2008), pp. 590–606.
[77] J. Meiser, D. Weindl, and K. Hiller. “Complexity of dopamine metabolism.” In: Cell
Communication and Signaling. Vol. 11. 34. BioMed Central Ltd, 2013, pp. 1–18.
[78] J. Dorszewska, M. Prendecki, M. Lianeri, and W. Kozubski. “Molecular effects of
L-dopa therapy in Parkinson’s disease.” In: Current Genomics. Vol. 15. 1. Bentham
Science Publishers, 2014, pp. 11–17.
[79] K. Westlund, R. Denney, R. Rose, and C. Abell. “Localization of distinct monoamine
oxidase A and monoamine oxidase B cell populations in human brainstem.” In:
Neuroscience. Vol. 25. 2. Elsevier, 1988, pp. 439–456.
[80] P. D. Azevedo. “Quantificação de neuromelanina em doenças neurodegenerativas.”
Master’s thesis. Faculty of Sciences and Technology, NOVA University of Lisbon,
2014.
[81] T. Hatano, A. Okuzumi, K. Kamagata, K. Daida, D. Taniguchi, M. Hori, H. Yoshino,
S. Aoki, and N. Hattori. “Neuromelanin MRI is useful for monitoring motor com-
plications in Parkinson’s and PARK2 disease.” In: Journal of Neural Transmission.
Vol. 124. 4. Springer, 2017, pp. 407–415.
[82] M. J. Aminoff. “Pharmacologic Management of Parkinsonism & Other Movement
Disorders.” In: Basic & Clinical Pharmacology. 13th ed. New York, NY: McGraw-
Hill Medical, 2015, pp. 447–61.
69

A
p
p
e
n
d
ix
Developed Interface
71
APPENDIX A. DEVELOPED INTERFACE
Fi
gu
re
A
.1
:
D
ev
el
op
ed
in
te
rfa
ce
in
M
at
la
b
fo
r
th
e
D
ic
e
Si
m
ila
rit
y
C
oe
ffi
ci
en
t
ca
lc
ul
at
io
n
be
tw
ee
n
tw
o
D
IC
O
M
s
co
nt
ai
ni
ng
se
gm
en
te
d
ar
ea
s.
T
he
ap
pl
ic
at
io
n
en
ab
le
s
th
e
lo
ad
in
g
an
d
vi
su
al
iz
at
io
n
of
tw
o
D
IC
O
M
im
ag
es
an
d
th
e
vi
su
al
iz
at
io
n
of
th
e
tw
o
se
gm
en
te
d
re
gi
on
s
ov
er
la
p.
T
he
ap
pl
ic
at
io
n
al
so
en
ab
le
s
th
e
us
er
to
zo
om
in
an
d
ou
t
on
al
li
m
ag
es
an
d
to
sa
ve
th
e
re
su
lte
d
im
ag
e.
72
